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The mesolimbic pathway has been implicated in the rewarding effects of drugs of 
abuse, and an important component of this pathway is the D1 dopamine receptor 
(D1DR). D1DRs desensitize upon agonist stimulation by several mechanisms, including 
a process involving receptor clustering and internalization. This process removes post-
synaptic D1DRs and may be a neuroadaptive mechanism associated with addiction to 
drugs of abuse, including ethanol. We measured localization of D1DRs in viable nucleus 
accumbens (NAcc) neurons from parasagittal explants. A sindbis RNA virus was used to 
mediate the expression of D1DRs containing an enhanced green fluorescent protein 
(eGFP) tag in these explants. The effects of dopamine and ethanol on D1DR localization 
were measured by changes in fluorescence intensity using two-photon laser scanning 
microscopy. Two-dimensional images from z-stacks of virally infected neurons displayed 
stable and homogenous fluorescence throughout the neuronal soma and processes. 
Dopamine (100 uM, 30 min) significantly enhanced the greatest increase of maximum 
 vi
fluorescence intensity in distinct regions of interest (ROIs) by approximately 40% 
compared to control neurons in the absence of dopamine. Ethanol pretreatment 
significantly enhanced dopamine-induced clustering. Neurons exposed to dopamine (50 
uM, 30 min) displayed receptor clustering only when pretreated with ethanol. Ethanol (50 
and 100 mM, 30 min.) pretreatment followed by dopamine (50 uM, 30 min.) enhanced 
the greatest increase of maximum fluorescence intensity by 44±3 and 108±9%, 
respectively, while dopamine (50 uM, 30 min) in the absence of ethanol pretreatment 
showed no clustering with peak increases in maximum fluorescence intensity of only 
3±2%. Ethanol (50 and 100 mM, 60 min) alone enhance the greatest increase of 
maximum fluorescence intensity by about 60% for both concentrations. Receptor 
clustering induced by dopamine, ethanol pretreatment of dopamine, or ethanol alone was 
partially blocked by the D1DR antagonist SCH 23390 (20 uM). These findings show that 
both dopamine and ethanol alter D1DR localization in NAcc neurons and suggest that a 
physical restructuring of D1DRs in this region may be involved in neuroadaptive 
mechanisms of ethanol action. 
 vii
Table of Contents 
List of Tables ..........................................................................................................x
List of Figures .........................................................................................................xi
Abbreviations.........................................................................................................xiv 
Chapter 1. Introduction and Literature Review .......................................................1 
1-1. General Introduction ...............................................................................1 
1-2. Two Families of Dopamine Receptors ...................................................5 
1-2.1. D1DR Desensitization .................................................................6 
1-2.1.1. D1DR Uncoupling from the G-Protein &  
 Desensitization ....................................................................7 
1-2.1.2. D1DR Phosphorylation & Desensitization......................8 
1-2.1.3. D1DR Internalization & Desensitization.......................10 
1-2.1.4. D1DR Down-regulation & Desensitization...................14 
1-3. Viral Mediated Gene Transfer ..............................................................15 
1-3.1. Naturally Occurring Sindbis Virus ............................................16 
1-3.2. Sindbis Expression Vector System............................................20 
1-3.2.1. pSinRep5 Vector............................................................23 
1-3.2.2. Helper Vectors...............................................................25 
1-4. Multi-photon Laser Scanning Microscopy............................................27 
1-5. Specific Aims ........................................................................................35 
Chapter 2: Subcloning eGFP-D1DR into the Sindbis Expression System ...........38 
2-1. Overview ...............................................................................................38 
2-2. Vector Propagation................................................................................38 
2-2.1. Quick Transformation ...............................................................39 
2-2.2. Plasmid DNA-Purification ........................................................39 
2-3. Preparation of eGFP-D1DR DNA into pSinRep5 Ligation ..................40 
2-3.1. Obtain the Appropriate DNA for Ligation ................................40 
2-3.2. Preparation of Appropriate DNA for Ligation ..........................42 
 
2-3.3. DNA Isolation............................................................................43 
2-3.4. Ligation......................................................................................44 
2-3.5. Slow Transformation of Ligation ..............................................44 
2-3.6. Plasmid DNA Purification.........................................................45 
2-3.7. Verification of the Correct Orientation of eGFP-D1DR in  
pSinRep5..............................................................................................46 
2-4. Production of Sindbis eGFP-D1DR ......................................................49 
2-4.1. Propagation of New eGFP-D1DR Containing pSinRep5  
Vectors ................................................................................................49  
2-4.2. in vitro Transcription of Sindbis eGFP-D1DR viral DNA........49 
2-4.3. Analysis of Sindbis RNA .........................................................50 
2-4.4. Electroporation of Sindbis RNA................................................51 
2-4.5. Sindbis Viral Stock Concentration ............................................55 
Chapter 3: Sindbis Viral Mediated Expression of eGFP-D1DR in Parasagittal 
Explants with Multi-photon Laser Scanning Microscopy ............................56 
3-1. Overview ...............................................................................................56 
3-2. Characterization Of Viral Expression System.......................................56 
3-2.1. Transfection of Neurons ............................................................56 
3-2.2. Viral Titer ..................................................................................60 
3-2.3. eGFP-D1DR function ................................................................61 
3-3. Parasagittal Mesolimbic Explant Characterization ...............................64 
3-3.1. Explant Introduction ..................................................................64 
3-3.2. Explant Methods........................................................................67 
3-3.3. Tyrosine Hydroxylase Immunohistochemistry of Explants ......67 
3-4. Multi-photon Laser Scanning Microscope Parameters and Detection of 
eGFP Fluorescence ..............................................................................71 
Chapter 4: Dopamine and Ethanol Induced Trafficking of eGFP-D1DR in  
Parasagittal Explants.....................................................................................83 
4-1. Introduction ...........................................................................................83 
4-2. Methods .................................................................................................85 
4-2.1. Explant Preparation. .................................................................85
 
                                              viii
 ix
4-2.2. Infection of Explant ...................................................................85 
4-2.3. Multi-photon Laser Scanning Microscopy................................85 
4-2.4. Explants Treatments ..................................................................86 
4-3. Image Analysis ......................................................................................89 
4-3.1. Statistical Analysis ....................................................................91 
4-4. Results ...................................................................................................91 
4-4.1. Control and Dopamine Experiments .........................................91 
4-4.2. Ethanol Pretreatment Experiments ..........................................103 
4-4.3. Ethanol Experiments................................................................113 
4-5. Discussion............................................................................................122 
Chapter 5: Summary, Conclusions and Future Directions...................................129 
5-1. Summary and Conclusions ..................................................................129 
5-2. Future Directions .................................................................................132 
Appendix I Recipes..............................................................................................136 
Appendix II Protocols ..........................................................................................139 
Bibliography ........................................................................................................142 
Vita  .....................................................................................................................162 
 x
List of Tables 
Table 1-1. pSinRep5 Genetic Information.............................................................24 
Table 1-2. DH(26)S Genetic Information..............................................................25 
Table 1-3. DH-BB Genetic Information. ...............................................................26 
Table 4-1. Treatment groups for control and dopamine experiments....................88 
Table 4-2. Treatment groups for ethanol pretreatment experiments......................88 
Table 4-3. Treatment groups for ethanol experiments...........................................89 
Table 4-4. Raw data for greatest increase in maximum fluorescence intensity  
 at the 60 minute time point as compared to baseline (0 minute time  
 point) for dopamine experiments. .....................................................99 
Table 4-5. Raw data for greatest increase in maximum fluorescence intensity  
 at the 60 minute time point as compared to baseline (0 minute time  
 point) for ethanol pretreatment experiments...................................108 
Table 4-6. Raw data for greatest increase in maximum fluorescence intensity  
 at the 60 minute time point as compared to baseline (0 minute time  
 point) for ethanol experiments. .......................................................118 
 xi
List of Figures 
Figure 1-1. Illustration of genetic information in naturally occurring sindbis as      
well as the vectors used in the sindbis expression system           
pSinRep5 and DH(26)S ...................................................................22 
Figure 1-2. Jablonski energy diagram for single photon excitation and                   
two-photon excitation. ......................................................................31 
Figure 2-1. Gel displaying release of the insert of eGFP-D1DR to be ligated into 
pSinRep5...........................................................................................41 
Figure 2-2. Cla I digestions of ligations of pSinRep5 and eGFP-D1DR...............47 
Figure 2-3. Gel displaying two samples of RNA made by in vitro transcription        
from pSinRep5 ligated with eGFP-D1DR. .......................................51 
Figure 2-4. Electorproated baby hamster kidney cells...........................................54 
Figure 3-1. Viable neurons expressing eGFP-D1DR after infection with the  
 sindbis virus. .....................................................................................59 
Figure 3-2. Cyclic AMP production demonstrates expression of functional  
 D1DRs...............................................................................................63 
Figure 3-3. Approximate parasagittal Plane used to make explants......................66 
Figure 3-4. Tyrosine Hydroxylase (TH) immunohistochemically stained 
 explants exemplifying the presence of dopaminergic cells in  
 parasagittal explants..........................................................................70 
Figure 3-4. Log-log plot of laser power versus fluorescence emission. ................74 
Figure 3-5. Wavelength of multi-photon laser versus the resulting fluorescence 
intensity as a percent of maximum. ..................................................76 
Figure 3-6. Two-dimensional representation of a z-axis stack. .............................79 
 xii
Figure 3-7. Different viewing angles from a three-dimensional image that was  
 created from a z-axis stack................................................................80 
Figure 3-8. Illustration of the three orthogonal planes that can be examined          
using Metamorph. .............................................................................82 
Figure 4-1. Example of a typical control neuron, the cell was treated with only  
 HBSS buffers ....................................................................................93 
Figure 4-2. Example of a typical neuron exposed to dopamine (50 uM) for 30 
minutes.. ............................................................................................94 
Figure 4-3. Example of a typical neuron exposed to dopamine (100 uM) for  
 30 minutes.........................................................................................95 
Figure 4-4. Example of a typical neuron exposed to dopamine (100 uM) for  
 30 minutes.........................................................................................96 
Figure 4-5. Example of a typical neuron exposed to SCH23390 (20 uM) plus  
 dopamine (100 uM) for 30 minutes. .................................................97 
Figure 4-6. Randomly assigned regions of interest as a percent of baseline (0 time 
point) for dopamine experiments. .....................................................98 
Figure 4-7. Control and dopamine experiment greatest increases in maximum 
fluorescence intensity at 60 minute time point compared to baseline (0 
minute time point)….......................................................................100 
Figure 4-8. Control and dopamine experiment frequency of increases in maximum  
 fluorescence intensity above 20% at the 60 minute time point  
 compared to baseline (0 minute time point). ..................................102 
Figure 4-9. Example of a typical neuron treated with dopamine (50 uM) for 30 
minutes.. ..........................................................................................104 
Figure 4-10 Example of a typical neuron exposed to ethanol (50 mM) for 30  
 x
 minutes followed by dopamine (50 uM) for 30 minutes. ...............105 
Figure 4-11. Example of a typical neuron exposed to ethanol (100 mM) for 30 
minutes followed by dopamine (50 uM) for 30 minutes. ...............106 
Figure 4-12. Example of a typical neuron exposed to SCH 23390 (20 uM) plus 
ethanol (100 mM) for 30 minutes followed by SCH233390 plus  
 dopamine (100 uM) for 30 minutes. ...............................................107 
Figure 4-13. Ethanol pretreatment greatest increases in maximum  
 fluorescence intensity at the 60 minute time point compared to  
 baseline (0 minute time point). .......................................................110 
Figure 4-14. Ethanol pretreatment frequency of increases in maximum  
 fluorescence intensity above 20% at the 60 minute time point  
 as percent of baseline (0 minute time point)...................................112 
Figure 4-15. Example of a typical control neuron treated only with HBSS. .......114 
Figure 4-16. Example of a typical neuron exposed to ethanol (50 mM) for  
 60 minutes.......................................................................................115 
Figure 4-17. Example of a typical neuron exposed to ethanol (100 mM) for 60 
minutes............................................................................................116 
Figure 4-18. Example of a typical neuron exposed to SCH23390 (20 uM) plus  
 ethanol (100 mM) for 60 minutes. ..................................................117 
Figure 4-19. Ethanol experiment greatest increases in maximum fluorescence 
intensity at the 60 minute time point compared to baseline (0 minute 
time point).......................................................................................119 
Figure 4-20. Ethanol experiment frequency of increases in maximum fluorescence  
 intensity above 20% at the 60 minute time point as percent of  
 baseline (0 minute time point.........................................................121
 
                                                                xiii  
 xiv
Abbreviations 
ACSF    artificial cerebral spinal fluid 
AMP    ampicillin 
AMPA    2-amino-3-hydroxy-5-methyl-4-isoxazole propionate 
Avg    average 
BHK    baby hamster kidney  
BSA    bovine serum albumin 
cAMP    cyclic adenosine 3', 5' -mono-phosphate 
CHO    Chinese hamster ovary 
ColE1    Colicin E1, Escherichia coli plasmid vector 
D1DR    D1 dopamine receptor 
DA    dopamine 
DAB    3-3'-diaminobenzidine tetrahydrochloride 
DEPC    diethylpyrocarbonate 
DNA    deoxyribonucleic acid 
EC50    effective concentration of 50% 
eGFP    enhanced green fluorescent protein 
Etoh    ethanol 
FBS    fetal bovine serum 
GABA    gamma-amino butyric acid 
GFP    green fluorescent protein 
G-protein   guanine nucleotide protein 
GPCR    G-protein coupled receptor 
GRK    G-protein receptor kinase 
HAD    high alcohol drinking 
HC    hippocampus 
HEK    human embryonic kidney 
LB    luria base 
Max    maximum 
 xv
MEM    minimum essential medium 
MPLSM   multi-photon laser scanning microscopy 
NMDA   N-methyl-D-aspartate 
NAcc    nucleus accumbens 
nuc. free H2O   nuclease-free water 
nsP    nonstructural proteins 
P    protocol 
PBS    phosphate buffered saline 
PFC    prefrontal cortex 
PKA    protein kinase A 
PKC    protein kinase C 
PS    packaging signal 
PSF    point spread function 
PSG    subgenomic promoter 
R    recipe 
RNA    ribonucleic acid 
ROI    region of interest 
SLM    single longitudinal mode 
TEM00    single transverse mode 
TH    tyrosine hydroxylase 
VTA    ventral tegmental area 
 
 1
Chapter 1. Introduction and Literature Review 
1-1. GENERAL INTRODUCTION   
Addiction is a poorly understood disorder defined as compulsive use and subsequent loss 
of control of drug self-administration even in the face of negative consequences 
(American Psychiatric Association, 1987; World Health Association, 1975). One widely 
accepted theory concerning the development of addiction is that drug exposure disrupts 
homeostasis by development of adaptive changes in neural systems which progress to a 
permanently altered state or allostasis of brain reward and stress responses (Koob and Le 
Moal, 2001). The reward threshold of addicts is, thus, altered caused by adaptations in 
reward and stress circuits of the addicted brain that fail to return to a homeostatic level. 
Many of the neural adaptations associated with addiction have not been discovered or 
characterized; clearly, a better understanding of these neural adaptations may lead to 
more effective treatments of addiction. 
 
The mesolimbic pathway has been implicated in the rewarding actions of drugs of abuse 
(Wise, 1996; Koob et al., 1998). Since addiction is associated with adaptations in reward 
circuits, this pathway is a candidate for alterations that may lead to addiction. The 
mesolimbic pathway originates in the ventral tegmental area (VTA) where dopaminergic 
neurons project to the NAcc as well as other areas (Ungerstedt, 1971; Oades and 
Halliday, 1987; Van Bockstaele and Pickel, 1995; Feldman et al., 1997). Medium spiny 
neurons make up approximately 90% of the neurons in the NAcc (Meredith, 1999; 
Gonzales et al., 2004) and project back to the VTA (Walaas and Fonnum, 1980; Heimer 
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et al., 1991). The VTA is subdivided into anterior and posterior regions that have 
different cell types and neuronal connections. The posterior VTA is implicated in reward 
based on effects of ethanol self-administration (Rodd-Henricks et al., 2000) while the 
anterior VTA is involved in mediating reward through pharmacological alterations of 
GABA receptors (Ikemoto et al., 1997; Boehm et al., 2002). The NAcc is subdivided 
(Zaborszky et al., 1985) into shell and core regions with different neuronal connections 
(Heimer et al., 1991; Usuda et al., 1998; O'Donnell et al., 1999). The shell and core are 
both implicated in different aspects of addiction; however, the precise roles of either 
region are still unknown (for review see Gonzales et al., 2004). Another important brain 
region that is intertwined with the mesolimbic pathway is the prefrontal cortex. It 
receives dopaminergic innervation from the VTA (Albanese and Bentivoglio, 1982; Carr 
et al., 1999) and delivers glutamatergic input to the NAcc (Carr et al., 1999; 
Groenewegen et al., 1999). The prefrontal cortex is also affected by drugs of abuse; for 
example, the morphology of neurons in both the prefrontal cortex and NAcc has been 
altered by drugs of abuse (Robinson and Kolb, 1997). 
 
In addition to morphological changes in the NAcc, drugs of abuse increased extracellular 
dopamine levels, and this increase in dopamine is believed to be associated with the 
rewarding effects of these drugs (Wise, 1996; Koob et al., 1998). The increased 
dopamine levels occurred by multiple mechanisms depending on the drug of abuse. For 
example, cocaine blocked the reuptake of dopamine into pre-synaptic terminals, thereby 
increasing the synaptic concentration of dopamine in the NAcc (for review see Wise, 
1984). In contrast, opiates increased dopamine in the NAcc by a disinhibition of GABA-
 3
ergic inter-neurons in the VTA (for review see Shippenberg, 1998). Ethanol may directly 
excite dopaminergic neurons in the VTA, resulting in an increased firing rate which then 
leads to enhanced dopamine release in the NAcc (Brodie et al., 1999). Also, ethanol 
injection enhanced extracellular dopamine levels in the NAcc (Imperato and Di Chiara, 
1986), and ethanol perfusion elevated dopamine levels in rat striatum (Yim et al., 1997).  
Thus, drugs of abuse increased extracellular dopamine levels in the NAcc albeit by 
different mechanisms. Understanding adaptations that occur following enhanced 
dopamine levels may lead to a better understanding of drug-induced neuronal 
mechanisms. 
 
Ethanol has also been shown to modulate other neurotransmitters. Extensive literature 
exists on the inhibition of excitatory N-methyl-D-aspartate (NMDA) receptors by ethanol 
(Dildy and Leslie, 1989; Hoffman et al., 1989; Lovinger et al., 1989; for review see 
Chandler et al., 1998). There is also extensive literature on the potentiation of gamma-
amino-butyric acid (GABA) and glycine receptor function by ethanol (Celentano et al., 
1988; for review see Chandler et al., 1998, for review see Mihic, 1999; for review see 
Davies, 2003). Ethanol has been shown to inhibit voltage-gated calcium channels (Wang 
et al., 1994; Widmer et al., 1998; Hendricson et al., 2003). Furthermore, ethanol alters 
cyclic adenosine 3’,5’-mono-phosphate (cAMP)-mediated cascades via changes in 
adenylyl cyclase activity or other components in this cascade (Tabakoff and Hoffman, 
1979; Hynie et al., 1980; Lucchi et al., 1983; Gordon et al., 1986; Maldve et al., 2002).  
Thus, ethanol appears to have several sites of action in the central nervous system. 
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The rewarding effects of ethanol are thought to be mediated by the mesolimbic dopamine 
pathway. In several studies, ethanol was self-administered directly into discrete areas of 
the VTA, demonstrating that ethanol produced rewarding effects (Gatto et al., 1994; 
Rodd-Henricks et al., 2000; Rodd et al., 2004). Additionally, increased dopamine levels 
were observed in the NAcc of rats which orally self-administered ethanol (Weiss et al., 
1993).  This indicates that ethanol-induced increases in dopamine levels in NAcc may 
underlie its rewarding effects. A consequence of increases in extracellular dopamine in 
the NAcc would likely be activation of native D1DRs because of the localization of these 
receptors in the NAcc (Hersch et al., 1995; Caille et al., 1996). Additional studies have 
suggested that mesolimbic D1DRs play a role in ethanol self-administration. Mice that 
have been genetically modified to lack D1DRs drank markedly less alcohol than their 
heterozygous and wild-type counterparts (El-Ghundi et al., 1998). In addition, D1DR 
agonists and antagonists reduced ethanol intake in rats (Dyr et al., 1993; Hodge et al., 
1997). Collectively, these studies suggest that the D1DRs in the mesolimbic pathway are 
mediating, at least in part, the rewarding effects of ethanol. 
 
Continued activation of D1DRs could lead to receptor desensitization, a type of neural 
adaptation that may be involved in addiction (Wise, 1996). Receptor desensitization is 
characterized by a reduced response despite continued presence of the receptor agonist 
(Sibley and Housley, 1994; Kallal and Benovic, 2000). The D1DR is a G-protein coupled 
receptor (GPCR); this family of receptors desensitize upon agonist stimulation in several 
ways, including internalization of the receptor (Kallal and Benovic, 2000). Interestingly, 
ethanol has been shown to produce changes in the surface expression of some receptors. 
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For example, internalization of the α1 subunit of the GABAA receptor in the cerebral 
cortex has been reported after chronic ethanol exposure (Kumar et al., 2003). 
Furthermore, hippocampal cultures exposed to ethanol for 4 days showed clustering of 
the NR1 subunit of the NMDA receptor with the pre-synaptic protein marker synapsin 
(Carpenter-Hyland et al., 2004). Internalization of receptors following chronic ethanol 
treatment may constitute a cellular mechanism for acute tolerance to ethanol.  
 
Ethanol’s effects on D1DR desensitization are not as well understood. Expression of 
D1DRs in response to chronic ethanol has been examined in several studies with varied 
results (Hruska, 1988; Hietala et al., 1990; Djouma and Lawrence, 2002; Quadros et al., 
2002; Vasconcelos et al., 2003). A better understanding of how D1DRs desensitize after 
ethanol administration is needed to determine if ethanol-induced D1DR trafficking could 
be a mechanism involved in the acute or chronic actions of ethanol. 
1-2. TWO FAMILIES OF DOPAMINE RECEPTORS  
Two families of dopamine receptors (D1 and D2) were originally defined by their 
opposite effects on adenylyl cyclase activity (for review see Huang et al., 2001). D1DRs 
stimulate adenylyl cyclase and were cloned by several labs (Dearry et al., 1990; Monsma 
et al., 1990; Sunahara et al., 1990; Zhou et al., 1990) while D2 dopamine receptors 
(D2DRs) inhibit adenylyl cyclase and were also cloned by several labs (Bunzow et al., 
1988; Dal Toso et al., 1989; Grandy et al., 1989b; Selbie et al., 1989; Todd et al., 1989). 
The human D1DR gene is located on chromosome 5 (Sunahara et al., 1990), and the 
human D2DR gene is located on chromosome 11 (Grandy et al., 1989a). Although these 
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receptors are encoded by different genes, it is hypothesized that they have a similar 
GPCR structure of seven hydrophobic transmembrane alpha-helices with an extracellular 
amino-terminal, a cytoplasmic carboxyl-terminal, and an intracellular third loop 
(Suryanarayana et al., 1992; for review see Bockaert and Pin, 1999). The seven 
transmembrane regions of D1DRs form binding sites for ligands on the extracellular side 
of the cellular membrane (for review see Bockaert and Pin, 1999). 
 
The dopamine D1 family of receptors, including the human D1 and D5 receptor subtypes, 
is commonly associated with the stimulatory guanine protein (G-protein, Gsα) which, 
acting through adenylyl cyclase, increases the synthesis of the second messenger 
molecule cAMP (for reviews see Kebabian and Calne, 1979; Huang et al., 2001). D1DRs 
may also couple to other G-proteins such as Goα (for review see Sidhu, 1998) and Gzα  
(for review see Huang et al., 2001) as well as stimulate additional second-messenger 
pathways. For example, there is evidence of D1DR stimulated nitric oxide production 
(Chen et al., 2003), intracellular calcium release (Lezcano and Bergson, 2002), and 
arachidonic acid release (Piomelli et al., 1991). Despite these other actions, cAMP is the 
gold standard for characterizing D1DRs (for review see Feldman et al., 1997; Huang et 
al., 2001).  
1-2.1. D1DR Desensitization 
Since drugs of abuse, including ethanol, increase dopamine levels in the NAcc, it is likely 
that D1DR activation will increase as a consequence of elevated dopamine. GPCRs, 
including D1DRs, desensitize upon agonist stimulation in three, possibly sequential, 
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ways (Kallal and Benovic, 2000). Specifically, D1DRs have been shown to desensitize 
upon agonist stimulation by 1.) uncoupling from the G-protein (Memo et al., 1982; Ng et 
al., 1994), 2.) internalization of the receptor (Ng et al., 1995; Dumartin, 1998; Martin-
Negrier et al., 2000) and 3.) down regulation of expression of the D1DR itself (Barton 
and Sibley, 1990; Gupta and Mishra, 1993). Agonist-induced desensitization is a 
decreased receptor-mediated response in the presence of continued agonist stimulation 
(for review see Sibley and Housley, 1994).  
1-2.1.1. D1DR Uncoupling from the G-Protein & Desensitization 
Initially, D1DR desensitization is indicated by a decrease in adenylyl cyclase activity or a 
decrease in cAMP production following agonist stimulation. There are many studies that 
support this type of desensitization. Adenylyl cyclase activity or cAMP production 
decreased during dopamine receptor stimulation in rat striatal slices (Memo et al., 1982), 
D384 cells derived from the human astrocytoma cell line G-CCM, (Balmforth et al., 
1990), NS20Y neuroblastoma cells (Barton and Sibley, 1990), striatal neurons 
(Chneiweiss et al., 1990), COS-1 monkey cells (Steffey et al., 1991), SK-N-MC 
neuroblastoma cells (Zhou et al., 1991), opossum kidney cells (Bates et al., 1993), Sf9 
insect cells (Ng et al., 1994) and in human embryonic kidney (HEK) cells (Tiberi et al., 
1996). These decreases were associated with an uncoupling of the receptor from the G-
protein. 
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1-2.1.2. D1DR Phosphorylation & Desensitization 
Phosphorylation of GPCRs may be involved in desensitization resulting from uncoupling 
of the receptor with the G-protein (Anderson and Jaworski, 1979). Agonist-induced 
phosphorylation of D1DRs expressed in insect Sf9 cells was associated with 
desensitization of cAMP production (Ng et al., 1994). Similarly, phosphorylation of 
D1DRs preceded desensitization of cAMP production in C6 glioma cells (Gardner et al., 
2001). Although cAMP desensitization has not been linked temporally with loss of 
D1DRs on the cell surface (Barton and Sibley, 1990; Bates et al., 1993), decreased high 
affinity receptor binding has been detected (Barton and Sibley, 1990). A decrease in high 
affinity binding is associated with receptor:G-protein uncoupling. High affinity binding is 
observed when the D1DR is coupled to the G-protein, and upon uncoupling, the D1DR 
undergoes a conformational change which reduces agonist affinity. Thus, D1DR 
phosphorylation decreased cAMP production which is linked to decreased high affinity 
binding which in turn is associated with G-protein uncoupling. The end result of 
phosphorylation may be uncoupling of the D1DR from the G-protein, thus beginning the 
desensitization process. 
 
If D1DR phosphorylation is a mechanism for receptor:G-protein uncoupling, controversy 
exists concerning the kinase(s) responsible for D1DR desensitization. The particular 
D1DR or cell model used may contribute to this confusion, since D1DRs of different 
mammalian species likely possess slight differences in phosphorylation sites and different 
cell systems may express different kinases. Cyclic AMP-dependent protein kinases and 
possibly Ca+2 –calmodulin protein kinases were first implicated in D1DR:G-protein 
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uncoupling (Memo et al., 1984). The desensitization of D1DR-mediated cAMP 
production was shown to be protein kinase A- (PKA, a cAMP-dependent kinase) 
dependent in permeabilized SK-N-MC neurotumor cells (Zhou et al., 1991). However, 
cAMP-dependent kinases were not required for D1DR phosphorylation in subsequent 
studies. Opossum kidney cells transfected with the cDNA of cAMP phosphodiesterase 
(an enzyme that catalyzes the hydrolysis of phosphodiester bonds in cAMP) surprisingly 
had no effect on the desensitization of cAMP production, suggesting that the 
accumulation of cAMP and thereby activation of cAMP-dependent kinases did not affect 
desensitization of cAMP production (Bates et al., 1993). PKA or protein kinase C (PKC) 
did not appear to mediate the phosphorylation of D1DRs in C6 cells, as activators of 
these enzymes had no effect on D1DR phosphorylation (Gardner et al., 2001). G-protein-
coupled receptor kinases (GRKs) caused direct phosphorylation of the D1DRs in HEK 
cells as the overexpression of both D1DRs and GRKs led to rapid desensitization of 
cAMP production (Tiberi et al., 1996).  
 
Additional studies involving mutations of the D1DR phosphorylation sites have aided in 
clarifying the role of phosphorylation in desensitization of cAMP production. PKA is at 
least partially responsible for D1DR desensitization, since a point mutation in the third 
cytoplasmic loop (T268), a phosphorylation site for PKA, reduced agonist-induced 
desensitization (Jiang and Sibley, 1999). Phosphorylation of the D1DR by GRK also 
appears to be important for desensitization, since a mutation of the GRK phosphorylation 
site on the carboxyl tail (T360) abolished agonist-induced desensitization (Lamey et al., 
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2002). Mutation studies also indicate that phosphorylation may be required for D1DR 
internalization, another form of GPCR desensitization, discussed in the next section. 
1-2.1.3. D1DR Internalization & Desensitization 
D1DR internalization, a cellular mechanism of desensitization (Kallal and Benovic, 
2000), is caused by endocytosis from the cell membrane and results in clustering of 
receptors away from the cell surface (Ariano et al., 1997). The localization of receptor 
clusters can indicate different states. For example, receptors clustered on the cell surface 
usually indicate sensitization. Conversely, if receptors cluster away from the cell surface, 
inaccessible to ligands, this often indicates desensitization.  
 
Internalization of D1DRs can be investigated by immunohistochemical techniques and 
binding studies of carefully prepared membrane preparations. Immunohistochemical 
detection of receptors has proven to be a valuable method for receptor localization 
studies; this technique gives an additional method for observing changes in receptor 
localization rather than relying solely on binding experiments which may not 
conclusively demonstrate which form of desensitization is occurring (internalization 
versus down-regulation of expression). Ng and colleagues (1994) reported that diffuse 
staining of immunohistochemically detected D1DRs became more punctate following 
dopamine stimulation in Sf9 cells. The punctate nature of staining, or clustering, was 
thought to represent the sequestration of receptors from the cell surface by endocytosis. 
This sequestration was blocked by the D1DR antagonist SCH 23390 (Ng et al., 1994). In 
another study, these investigators reported that internalization of the D1DR, but not 
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adenylyl cyclase activity desensitization, was blocked by concanavalin A or sucrose 
pretreatment (Ng et al., 1995). Others have demonstrated that similar treatments inhibit 
the internalization of the archetype GPCR, the β-adrenergic receptor (Yu et al., 1993). 
Blocking the internalization of D1DRs in C6 glioma cells by sucrose or concanavalin A 
did not inhibit dephosphorylation, suggesting that internalization is not required for 
dephosphorylation of the receptor (Gardner et al., 2001). Ariano et al. (1997) 
demonstrated a loss of D1DR immunofluorescence after dopamine stimulation in CHO 
cells, primary striatal cell cultures, and striatal slice preparations which was blocked by 
the dopamine receptor antagonists butaclamol or SCH 23390. In the same study, direct 
evidence of membrane endocytosis was observed by FM1-43 incorporation of the lipid 
bilayer into endocytosed vesicles following dopamine stimulation, suggesting D1DR 
internalization. A redistribution of immunostained D1DRs upon the dopamine agonist 
SKF 82958 stimulation for 1 hour was observed in fixed primary dissociated striatal cells 
by Martin-Negrier and colleagues (2000). That study indicated that dendritic D1DRs 
internalized, and this process was reversed 7 hours after agonist removal and was blocked 
by the D1DR antagonist SCH 23390. Conversely, D1DRs expressed in axons may have 
shown clustering on the cell surface upon activation by SKF 82958 (Martin-Negrier et 
al., 2000). Another lab assessed in vivo treatment with SKF 82958 or amphetamine and 
observed internalization of D1DRs in cell bodies and dendrites of striatal neurons, and 
injections of SCH 23390 blocked this internalization as detected by electron microscopy 
(Dumartin et al., 1998). Finally, D1DR internalization was observed after application of 
the dopamine precursor, L-Dopa, by immunocytochemistry; however, ropinirole, a 
dopamine partial agonist, did not cause internalization (Muriel et al., 2002). Therefore, 
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multiple labs have demonstrated that D1DRs undergo internalization, and this process 
can be inhibited with D1DR antagonists or by inhibition of endocytosis. 
 
The role of phosphorylation in D1DR desensitization by internalization was clarified 
recently when a model for a step-wise phosphorylation of the D1DR was proposed (Kim 
et al., 2004a). In HEK cells, phosphorylation appears to occur first in the carboxyl 
terminus and then in the third cytoplasmic loop. This step-wise phosphorylation allows 
for conformational changes of the D1DR, allowing arrestin to bind to the receptor, 
thereby causing endocytosis or internalization of the receptor (Kim et al., 2004a). 
Arrestin functions as a scaffolding protein associated with endocytosis of GPCRs (Zhang 
et al., 1996b). Other studies have supported this model. Truncation of the D1DR carboxyl 
tail at amino acid 351 resulted in a loss of dopamine-induced internalization to a 
perinuclear membrane of HEK cells; however, this mutation still desensitized the 
activation of adenylyl cyclase (Jackson et al., 2002). Mutations in the distal carboxyl tail 
failed to induce internalization of the D1DR but did decrease cAMP levels upon agonist 
exposure in CHO cells (Lamey et al., 2002). These studies demonstrate a requirement for 
phosphorylations at different locations on the D1DR as a mechanism for internalization 
as proposed in the model from the Sibley lab, whereas multiple phosphorylations are not 
required for desensitization associated with receptor:G-protein uncoupling.  
 
Numerous radioligand binding studies have sought to determine the types of 
dopaminergic agonists required for D1DR desensitization. In NS20Y cells, the maximum 
loss of dopamine receptors on the cell surface, determined by [3H] SCH 23390 binding 
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on membrane preparations, was observed after 3 hours of stimulation by the agonist 
dopamine (Barton and Sibley, 1990). Similarly, more than 1 hour exposure of either 
dopamine or the full D1DR agonist, SKF 82958, resulted in equivalent losses of 
antagonist binding in SK-N-MC cells, while the partial D1DR agonist, SKF 38393, 
resulted in less desensitization than a full agonist in these cells (Zhou et al., 1991). The 
D1DR antagonist, SCH 23390 had no effect on D1DR binding but blocked the effects of 
dopamine (Zhou et al., 1991). Therefore, it appears that maximal loss of D1DR binding 
from plasma membranes depended on receptor activation by full agonists, while partial 
agonists were less effective and antagonists were ineffective at causing a loss of receptor 
binding on the cell surface. Depending on the type of membrane preparation studied, it 
can be difficult to differentiate between internalization of the receptor vs. down-
regulation of its expression since both forms of desensitization result in a decrease in 
surface binding.  
 
Other forms of stimulation not involving direct receptor activation also appear to induce 
D1DR desensitization measured by loss of plasma membrane binding. Pretreatment of 
NS20Y cells with CPT-cAMP, a membrane permeable analog of cAMP, decreased 
receptor binding on plasma membranes in a dose-dependent manner, while the cAMP 
antagonist, RP-cAMPS, blocked this effect (Black et al., 1994). Sibley and colleagues 
have also shown that CPT-cAMP desensitization of adenylyl cyclase activity was 
maximally and temporally different from the CPT-cAMP induced decrease in D1DR 
binding. Furthermore, a decrease in high affinity D1DR binding closely matched that of 
reduced adenylyl cyclase activity. These findings demonstrate that direct receptor 
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activation is not required for D1DR desensitization and provide further evidence that the 
uncoupling of receptor and G-protein, and not D1DR internalization. is the cause of 
decreased cAMP production (Black et al., 1994). 
1-2.1.4. D1DR Down-regulation & Desensitization 
A long-term form of desensitization is down-regulation of protein expression (Kallal and 
Benovic, 2000). As discussed previously, it is often difficult to distinguish down-
regulation of expression from internalization in binding studies since both mechanisms 
result in decreased cell surface binding. Internalization may thus be mistaken as down-
regulation.  
 
There appears to be a time factor in agonist stimulation that determines whether the form 
of desensitization is internalization of the receptor or down-regulation of receptor 
expression. If protein synthesis was required, as observed with longer duration (3 hour) 
of receptor activation, new receptors were likely synthesized, thereby suggesting an 
initial down-regulation of receptor expression. If protein synthesis was not required, as 
observed with shorter periods (30 minutes) of stimulation, internalization of receptors 
likely occurred, and receptors will return to basal levels by re-insertion into the plasma 
membrane. Thus, a return to basal receptor levels and the requirement of protein 
synthesis clarifies which form of desensitization has taken place (Barton and Sibley, 
1990). Long exposure (72 hours) to dopamine or SKF 38393 decreased D1DRs as 
measured by homogenated tissue binding and also decreased a portion of the 
heterotrimeric stimulatory G-protein, Gsα as measured by Western blot analysis (Gupta 
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and Mishra, 1993). These studies indicate that prolonged D1DR activation may produce 
down regulation not only in receptor expression, but also in the stimulatory G-protein 
subunit associated with transduction of the D1DR.  
 
In summary, stimulation of D1DRs by the naturally occurring agonist dopamine and 
other dopaminergic agonists such as SKF 82958 results in desensitization of the receptor. 
Different mechanisms of desensitization are possible, including uncoupling of the 
receptor from the G-protein, internalization of the receptor, or down-regulation of 
receptor expression. I propose that dopamine and ethanol will induce desensitization of 
D1DRs via the mechanism of receptor internalization. The D1DR is an important 
component in the mesolimbic pathway (Hersch et al., 1995; Caille et al., 1996), and this 
pathway is associated with the rewarding actions of ethanol (Wise, 1996; Koob et al., 
1998). Therefore, desensitization of D1DRs may be involved in the cellular mechanisms 
of ethanol abuse and addiction. 
1-3. VIRAL MEDIATED GENE TRANSFER 
I hypothesize that D1DR desensitization by internalization is a neural adaptation that 
occurs in ethanol abuse. To test this hypothesis, I will use viral-mediated gene transfer of 
the D1DR containing a fluorescent marker, eGFP (eGFP-D1DR), to provide a method for 
monitoring D1DR trafficking in intact neurons of the NAcc. The sindbis virus has been 
used successfully to transfect neural preparations with proteins of interest (D'Apuzzo et 
al., 2001; Diaz et al., 2004; Ehrengruber et al., 1999; Jeromin et al., 2003; Kim et al., 
2004a; Shi et al., 1999; Xiong et al., 1989). The sindbis pseudovirus has been used to 
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induce expression of eGFP-D1DR in several neuronal preparations, including dissociated 
cells, explants, and in vivo (Diaz et al., 2004). 
 
The transfection of post-mitotic neurons has been accomplished using a variety of viral 
expression systems, including adenovirus (Le Gal La Salle et al., 1993), adeno-associated 
virus (Xiao et al., 1997), and herpes simplex virus (Casaccia-Bonnefil et al., 1993; 
Neumaier et al., 2002). However, the sindbis virus was chosen for these experiments 
since the viral constructs are quite selective for neurons compared to glia (Gwag et al., 
1998). Additionally, the time course of infection is rapid, with significant transfection 
levels in one to three days.  
1-3.1. Naturally Occurring Sindbis Virus 
Sindbis is considered an arbovirus, or arthropod-borne virus. The World Health 
Organization in 1967 defined arboviruses as  
“viruses which are maintained in nature principally, or to an important 
extent, through biological transmission between susceptible vertebrate 
hosts by haematophagous arthropods; they multiply and produce viremia 
in the vertebrates, multiply in the tissues of arthropods, and are passed on 
to new vertebrates by the bites of arthropods after a period of intrinsic 
incubation.”  
 
Virus-infected vertebrates have varying responses from no significant infection to 
encephalitis and death (Schlesinger and Schlesinger, 2001). 
 
The sindbis virus belongs in the genus alphavirus of the family of Togaviridae 
(Schlesinger and Schlesinger, 2001). The sindbis virus is closely related to another 
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alphavirus in structure and infectivity, the semliki forest viruses. The original strain, 
AR339, of the sindbis virus was collected from mosquitoes near Sindbis, Egypt in 1952 
(Taylor et al., 1955). The alphavirus genome is comprised of a single strand (Strauss et 
al., 1968) of positive-sense RNA, capped at the 5’ terminus and polyadenylated at the 3’ 
terminus (Schlesinger and Schlesinger, 2001). The RNA strand is encapsulated by an 
icosahedral (20-sided) homomeric assembly of 240 molecules of capsid protein which is 
enveloped upon host cell budding by a lipid bilayer, producing a virion of a total diameter 
of approximately 70 nm (Schlesinger and Schlesinger, 2001; Ehrengruber, 2002). The 
viral RNA products are differentiated on the basis of the sedimentation coefficient of two 
resulting RNA strands: the 49S RNA (which is the total genomic RNA) and the 
subgenomic 26S RNA fraction (which encodes the structural genes of the virus).  
 
Projecting through the lipid bilayer of the virus are glycoprotein spikes made of 80 
trimers consisting of three heterodimers of E1and E2 glycoproteins (Schlesinger and 
Schlesinger, 2001; Ehrengruber, 2002). These glycoprotein spikes participate in infection 
as well as viral budding. Alphaviruses infect cells through binding of cell surface 
receptors in the major histocompatibility class I molecules such as laminin (for review 
see Marsh and Helenius, 1989). The glycoprotein E2 is most likely the protein which 
attaches the virus to the host cell by interactions with laminin. Evidence for this is based 
on mutations in the E2 protein, which were defective in binding to chicken embryo 
fibroblasts yet showed normal assembly and release (Dubuisson and Rice, 1993). 
Endocytosis is the general method of host cell entry by alphaviruses (for review see 
Marsh and Helenius, 1989). 
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Upon entry into the host cell, the genomic RNA acts both as messenger RNA for the 
nonstructural proteins and also as a template for both negative stranded RNA for 
structural proteins as well as additional positive stranded RNA(Schlesinger and 
Schlesinger, 2001). The messenger RNA is translated as a single polyprotein for the first 
two-thirds of the genome. This polyprotein is cleaved to give rise to the nonstructural 
genes nsP1, nsP2, nsP3 and nsP4. The final one-third of the genome is also translated into 
a structural polyprotein consisting of capsid-P62-6K-E1.  
 
The nonstructural protein genes (nsP1-4) act as replication enzymes. nsP1 plays a role in 
the synthesis of negative stranded RNA (Wang et al., 1991) and is also important in the 
methylation of the 5’ terminal cap structure on genomic RNA (Mi et al., 1989; Ahola and 
Kaariainen, 1995). nsP2, found in high concentrations in the nucleus (Peranen et al., 
1990), is implicated in the regulation of negative stranded RNA (Sawicki and Sawicki, 
1993), in subgenomic RNA synthesis (Suopanki et al., 1998), and proteolytic processes 
of the nsPs (Ding and Schlesinger, 1989). nsP3, acting as a phosphoprotein, is implicated 
in positive stranded RNA synthesis and as a negative stranded RNA replicase (De et al., 
2003). nsP4 is believed to be important for RNA polymerase (Li and Stollar, 2004).  
 
There is a proposed model for the RNA synthesis mechanism through nonstructural 
proteins and polyproteins (Lemm et al., 1994). The nsPs are translated as polyproteins 
nsP1234 and nsP123. These polyproteins include all 4 proteins sequentially or nsP1-3 
depending on an in-frame opal codon better known as the UGA stop codon. nsP1234 is 
 19
cleaved to nsP123 and nsP4. These two proteins then form a complex which is implicated 
in initiating negative-strand RNA synthesis. A positive-strand RNA is also synthesized 
with an nsP123-nsP4 complex, although inefficiently. nsP123 is later cleaved to nsP1, 
nsP2 and nsP3. The cleavage halts negative strand RNA synthesis, although in 
conjunction with host cell factors the four separated nonstructural proteins can synthesize 
positive strand RNA and subgenomic or structural gene RNA. This model explains the 
low level of negative strand RNA because nsP123 does not recombine to make more 
negative strand RNA; therefore new protein synthesis is required for more negative 
strand RNA synthesis. 
 
Structural proteins, encoded in subgenomic 26S RNA, are produced quickly within 2-3 
hours after infection (Schlesinger and Schlesinger, 2001). A polyprotein that includes the 
capsid- p62- 6K- E1 is translated; however, the capsid is cleaved early in synthesis. Once 
the capsid is removed, the remaining polyprotein, p62- 6K- E1, is shuttled by the host cell 
to the endoplasmic reticulum where oligosaccharides are attached. The polyprotein then 
continues through to an intermediate compartment where palmitoylation occurs. In the 
Golgi complex, host oligosaccharides are further altered. These oligosaccharides are 
important for glycoprotein spike formation. p62 is cleaved to form E2 (Schlesinger and 
Schlesinger, 1972) and E3 in the trans-Golgi vesicle. The rest of the polyprotein is 
cleaved by host cell enzymes at differing areas along the path to the cell membrane, 
depending on the host cell. 
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The virion assembles after structural protein synthesis (Schlesinger and Schlesinger, 
2001). Initially, a portion of the nsP1 RNA binds to the capsid protein (Weiss et al., 
1994). Pre-formed nucleocapsids then interact with the host cell plasma membrane where 
viral glycoproteins are present. Additional viral glycoproteins then diffuse to the plasma 
membrane, bind to the capsid, and induce the membrane to round, forming the capsid 
with the membrane and finally fusing, thus releasing the newly formed virion. The 6K 
protein appears to be important but not required in virion budding since mutations of this 
gene only result in a decreased amount of released virus from BHK cells (Schlesinger et 
al., 1993). 
1-3.2. Sindbis Expression Vector System 
The sindbis two-vector expression system was originally commercially available from 
Invitrogen (Carlsbad, CA cat # K750-01). One vector encodes the same non-structural 
replicase genes (nsP1-4) as well as a gene of interest, and another vector encodes the 
structural genes (capsid- p62- 6K- E1) for the virus (Liljestrom and Garoff, 1991; 
Bredenbeek et al., 1993). The sindbis pseudo-virus expression system results in a similar 
virion as the naturally occurring sindbis virus with a lipid bilayer and capsid. Naturally 
occurring sindbis is different in that a single RNA strand encodes for the nonstructural 
genes and for the subgenomic structural genes. The separation of the genomic 
information into two vectors allows a gene of interest to be included into the subgenomic 
pseudo-virus system, thus enabling synthesis of high levels of the protein of interest and 
better control of infectivity. The infectivity is controlled because the structural gene RNA 
is not repackaged into the virion. The helper vector, which encodes the structural genes, 
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does not have a packing signal (PS), thus constituting a pseudoviral system that ensures 
no new structural genes are made after the first infection. 
 










DH(26)S Sindbis Expression System Vector 
 
 
Figure 1-1. Illustration of genetic information in naturally occurring sindbis as well 
as the vectors used in the sindbis expression system pSinRep5 and DH(26)S. Non-
structural protein genes 1-4 (nsP1-4) are encoded in naturally occurring sindbis and in the 
pSinRep5 vector. Structural Genes are encoded in naturally occurring sindbis and in 
DH(26)S. All three vectors encode a subgenomic promoter (PSG). pSinRep5 and DH(26)S 
both encode ampicillin (AMP) resistance, bacterial uptake information (ColE1), and the 
Sp6 promoter. pSinRep5 only encodes the packaging signal needed for virions made by 
the sindbis expression system to include this vector so that a gene of interest can be 
expressed. See Tables 1-1. through 1-3. for further description of genetic information. 
AMP ColE1 Sp6 PSG Structural Genes
PSGnsP1-4 Structural Genes 
AMP ColE1 Sp6 nsP1-4 PSG Gene of Interest PS 
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1-3.2.1. pSinRep5 Vector 
The vector for sindbis that encodes the nonstructural genes and the gene of interest is 
designated pSinRep5 (Bredenbeek et al., 1993); it contains 9951 nucleotides without the 
gene of interest. This vector has several important genetic areas as indicated in Table 1-1: 
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Table 1-1. pSinRep5 Genetic Information 
Genetic Area Approximate bp Encoding 
the Genetic Area 
Purpose of Genetic Area 
Packaging signal (PS) (1-60) allows for packaging into 
the capsid to form pseudo-
virions 
nonstructural protein genes 
1- 4 (nsP1-4) 
(60-7598) encodes replicase proteins 
used for in vivo replication 
of recombinant and 
subgenomic RNA 
subgenomic promoter (PSG) (7580-7603) allows the transcription of 
the gene of interest 
Cloning sites (6) (7647-7689)  
 
where insertion of a gene of 
interest is designed after the 
subgenomic promoter  
poly-A sequence (7997-8033) stabilizes the RNA 
linear restriction sites (3) (8047-8067) cleavage sites present where 
the vector is linearized for in 
vitro transcription; the 
enzyme used should cut the 
vector only in this position 
Ampicillin resistance gene 
(AMP) 
(8227-9085) gene so that the vector can 
be selectively mass 
produced in bacteria 
ColE1 (9232-9861) origin for high copy 
replication in bacteria 
Sp6 promoter region (Sp6) (9933-9951) promoter allows for the 





1-3.2.2. Helper Vectors 
DH(26)S is a defective helper vector that encodes for structural proteins (Bredenbeek et 
al., 1993). This vector is 8189 nucleotides. The E1 and E2 glycoproteins of the defective 
helper DH(26)S are derived from a neurovirulent form of sindbis and are more selective 
for neurons than glia (Gwag et al., 1998). This helper vector also has several important 
genetic areas similar to pSinRep5 but is different in that it encodes structural proteins but 
not a packaging signal or any non-structural proteins. 
Table 1-2. DH(26)S Genetic Information 
Genetic Area Approximate bp Encoding the Genetic Area 
subgenomic promoter (PSG) (2073-2096) 
structural genes 1-4 
capsid 
p62 (E2 & E3) 







poly-A sequence (6197-6233) 
Ampicillin resistance gene (AMP) (6465-7323) 
Co1E1 (7470-8099) 




DH-BB is another helper vector encoding structural genes that form the capsid and other 
structural elements of the virion (Bredenbeek et al., 1993). DH-BB is so named because it 
is a defective helper made using restriction enzymes BspMII and Bam HI. This vector 
contains 6729 nucleotides. It does not contain packaging signals (unlike pSinRep5), so 
structural genes are not packaged to form a second round of virions. This ensures only 
one round of infection since there will theoretically be no capsids, glycoproteins, or any 
other structural genes present after the initial infection.  
Table 1-3. DH-BB Genetic Information. 
Genetic Area Approximate bp Encoding the Genetic 
Area 
subgenomic promoter (PSG) (671-694) 
structural genes 1-4 
capsid 
p62 (E2 & E3) 







poly-A sequence (4795-4831) 
ampicillin resistance gene (AMP) (5005-5863) 
Co1E1 (6010-6639) 




1-4. MULTI-PHOTON LASER SCANNING MICROSCOPY 
For this project, the eGFP-tagged D1DR that is transfected using the sindbis pseudovirus 
was localized by multi-photon laser scanning microscopy (MPLSM). This technique 
allows for live-cell, real-time imaging of native neurons which is critical for localizing 
proteins such as receptors for trafficking (Denk and Svododa, 1997). MPLSM offers an 
advantageous method for detecting D1DR desensitization by clustering and 
internalization in the presence of dopamine and ethanol stimulation. 
 
Other forms of microscopy, such as light, electron and confocal, have limitations (Denk 
and Svododa, 1997) that make these techniques inadequate for testing the hypothesis of 
this dissertation. Although light microscopy can be used on living tissue with little photo-
damage, light scattering caused by tissue inhomogeneities degrades the resolution and 
contrast of light detection. Additionally, the methods used to mark proteins of interest, 
such as the D1DR, often require fixation of the tissue, leaving the tissue no longer viable 
when using light microscopy. Electron microscopy, although ideal for definitive protein 
localization, requires fixation of the tissue, thereby live cell, real-time imaging cannot be 
completed. Confocal microscopy has higher depth of tissue penetration compared to light 
microscopy, but light scattering is still an issue. In fact, light scattering for confocal 
microscopy leads to additional photo-damage of not only the tissue but the fluorophore, 
referred to as photo-bleaching. Photo-damage is a significant problem in confocal 
microscopy; excitation outside of the detection focal plane is not only wasteful but causes 
photo-damage of both the fluorophore and tissue.  
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There are several major advantages to multi-photon laser scanning microscopy, in 
particular when compared to its single-photon excitation counterpart, confocal laser 
scanning microscopy (Nakamura, 1999). First, the volume of excitation is very small in 
multi-photon excitation since the probability of two photon absorption is proportional to 
the quadratic of the intensity of the excitation field. The decreased volume of excitation 
allows not only for decreased bleaching of fluorophores but also an optical sectioning 
effect when coupled with raster scanning. Second, there is a reduction of light scattering 
within a sample with multi-photon excitation since the wavelength of the pulsed laser is 
approximately twice as long as the single photon wavelength, thereby decreasing 
Rayleigh scattering effects, resulting in more efficient excitation, and also causing less 
photo-damage. Third, a deeper penetration of the laser into biological samples is possible 
due to the near-infrared laser wavelength (which has decreased electron transition and 
molecular vibration absorption) and greater peak power levels.  
 
There are few disadvantages to multi-photon versus confocal microscopy. One major 
concern is the price of multi-photon lasers; although with more market competition 
spurred by scientific demand, price may not be a problem in the future. Another concern 
is the difficulty to scan multiple wavelengths in the same specimen. This makes MPLSM 
not useful for imaging double-labeled tissue. Not only are the excitation spectra wider for 
multi-photon excitation (causing spectral overlap for many fluorophores) but sequential, 
repeated retuning of the laser is difficult if the same laser properties are to be maintained. 
Finally, despite the fact that there is less out-of-focus emission in multi-photon excitation, 
the resolution is not greater than confocal microscopy (Nakamura, 1999). Resolution is 
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often defined through the point spread function (PSF) which is inversely proportional to 
the wavelength of excitation. Therefore, the shorter the wavelength, the better the 
resolution, and multi-photon excitation utilizes longer wavelengths than confocal 
excitation.  
 
The use of two-photon laser scanning microscopy has been more than 50 years in the 
making. This technique is only recently made possible by advances in technology though 
it has long been hypothesized. The theory for multi-photon excitation was first described 
in the dissertation of Maria Göppert-Mayer in 1931 (for review see Masters and So, 
2004). Interestingly, in 1963 Maria Göppert-Mayer would receive a Nobel Prize in a 
different field for the development of the nuclear shell model. In her dissertation Dr. 
Göppert-Mayer described two-photon absorption and emission (Masters and So, 2004). 
In one-photon excitation, as shown in the Jablonski Energy diagram in Figure 1-2, a 
photon excites an electron from the ground state to an excited state. This electron then 
relaxes to a lower energy state, releasing the energy received from the incident photon as 
a different photon of fluorescence. In one-photon excitation the excitation wavelength is 
always longer then the emission wavelength because there is energy lost between 
electronic vibrational states as indicated by the small dashed lines in Figure 1-2. For two-
photon absorption the first photon excites an electron from the ground state to a virtual 
state. The second photon must excite the electron from that virtual state to the excited 
state before the electron returns to the ground state. Absorption by the second photon 
must therefore happen on the order of femto-seconds. With the low probability of two 
photons completing this excitation, a high intensity light is required. In fact, Dr. Göppert-
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Mayer derived that the probability of two-photon absorption is quadratically related to the 
excitation light intensity; therefore, multi-photon fluorescence is a nonlinear optical 
process. 
 
single photon excitation two-photon excitation 
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Figure 1-2. Jablonski energy diagram for single photon excitation and two-photon 
excitation. Curved arrows are photons, different colors represent different wavelengths. 
The red arrows are changes in electron energy state, S0 is the ground state while S1 and S2 
are excited singlet states. The small dashed lines in between singlet states are electron 
excited vibrational states. Excited rotational energy states are not pictured. A virtual state 






    virtual
     state 
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Lasers are an intrinsic element of multi-photon excitation, particularly with the 
requirement for a high intensity light. Laser is an acronym for light amplification by the 
stimulated emission of radiation (Maiman, 1960; Hitz et al., 2001). All lasers have three 
things in common, they are: 1) monochromatic, 2) collimated and 3) coherent (Hitz et al., 
2001). Monochromatic refers to the fact that all the lasing photons have the same 
wavelength and are thus the same color. Collimation describes the directional nature of 
the beam due to the low rate of expansion. Finally, coherence, which requires the laser to 
be both monochromatic and collimated, refers to phase matching of all photons, the 
alignment of the crests and troughs of the waves. 
  
Several basic components make up the laser itself, which can also be considered an 
optical oscillator or an optical amplifier with partial positive feedback (Hitz et al., 2001). 
The most important component is the lasing material. This material must undergo 
population inversion which is the change in the electronic energy state in the lasing 
medium. When a photon of the proper frequency passes near an electron in the excited 
state contained within the lasing medium, this photon induces the electron to drop from a 
higher excited state to emit a photon. The emitted photon induces the same energy drop 
of an additional electron causing a cascade of electron drops and photon emissions. The 
device that provides the energy source that initiates this process is the pump, another key 
component of a laser.  The pump excites the lasing medium causing a population 
inversion. Mirrors, a third key component of the laser, are placed on either side of the 
lasing cavity, allowing this cascade of photons and electrons to continue. The final 
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component of a laser is an output coupler. This component is usually a mirror, modified 
to allow a small portion of the emission to exit the lasing cavity. 
 
The first laser was built in 1960 by Maiman (Maiman, 1960). His short two page report 
would impact many fields, from electronics to medicine. Maiman has been nominated 
twice for the Nobel Prize and has also won the Asian equivalent to the Nobel Prize, the 
Japan Prize, in 1987. Maiman made a laser using ruby as the lasing medium, which had 
been silvered, effectively creating mirrors on two parallel faces. The ruby was then 
irradiated by a high power flash lamp which acted as a simple pump.  
 
Once functioning lasers had been achieved, the further development of non-linear optical 
processes such as laser pulsing for multi-photon excitation proceeded. The first 
experimental two-photon excitation fluorescence was observed in 1961 by Kaiser and 
Garrett of Bell Telephone Laboratories. Crystals of CaF2:Eu2+ were excited with a 
reported wavelength of 694 nm from a ruby optical maser which resulted in blue 
fluorescent light with a reported wavelength of 425 nm from Eu2+ relaxing from the 
excited state. A log-log plot of fluorescence intensity vs. excitation intensity resulted in a 
slope of 2 indicating two-photon nonlinear excitation. 
 
Another important development for two-photon laser scanning microscopy was made 
with the self-mode-locked titanium:sapphire (Ti:Al2O3) laser (Spence et al., 1991). These 
lasers have a large working range of 700-1,100 nm as well as mode locking capabilities 
causing pulse widths in the femto-second range optimal for multi-photon excitation. An 
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advantage of the titanium-sapphire laser is the tunability of the laser, with a pulsing 
wavelength slightly less than the working range of ~770-950 nm. In order for lasers to be 
tunable the laser medium must have a broad gain profile so that different wavelengths can 
be selected. Lasing must then be restricted to a single transverse mode (TEM00) using an 
intracavity aperture (Hitz et al., 2001). For many titanium:sapphire lasers, the aperture is 
a metal slit. The emission is then finally limited to a single longitudinal mode (SLM) by a 
dispersive element such as a prism. The combination of the lasing medium, a metal 
aperture and prism provide tuning, while the ability to make the laser pulse in the femto- 
to pico-second range allow multi-photon excitation. 
 
Another significant advancement in the development of MPLSM occurred with the 
development of nonlinear scanning optical microscopes based on second-harmonic 
generation in 1977 (Sheppard and Kompfner, 1978). This microscope utilizes excitation 
light focused to a small volume, and then either the light or the specimen can be raster 
scanned to form an image. Sheppard and Kompfner theorized the ability for added 
resolution (including three-dimensional imaging) since excitation occurs in such a small 
volume, also limiting heating of the specimen, making this technique optimal for 
biological sampling. Additionally, nonlinear optical techniques are optimal since such a 
pulsed laser as required for MPLSM would result in an overall decrease in sustained 
power but much greater peak power. Confocal microscopy, the single photon excitation 
equivalent of multi-photon laser scanning microscopy, was also introduced by the same 
group (Sheppard and Choudhury, 1977).  
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In 1990 all the pieces were finally available to produce a multi-photon laser scanning 
microscope in the lab of Watt Webb at Cornell University (Denk et al., 1990). The 
resultant two-photon laser scanning microscope revolutionized the field. A colliding-
pulse mode-locked dye laser was used as the now standard titanium:sapphire was not yet 
available with proper pulsing. This combination of laser scanning microscopy 
complimented by a mode-locked laser pulsed in the near infrared wavelength allowed for 
the fluorescent microscope detection of two-photon excitation of molecules.  
 
MPLSM provides optimal characteristics (viability of tissue, real-time imaging, 
resolution in heterogeneous tissue) and therefore encompasses the best technique for 
localizing eGFP-D1DRs in viable cells growing in slice cultures for real time analyses. 
Several antecedents to MPLSM have been described including lasers and nonlinear 
scanning optical microscopes. These fundamental developments help to clarify the 
technical aspects of the techniques used in this dissertation. 
1-5. SPECIFIC AIMS 
Mesolimbic dopamine neurons project from the VTA to the NAcc. This pathway is 
believed to be important in establishing the rewarding effects of drugs of abuse including 
alcohol ( Wise, 1996; Koob et al., 1998). One potential molecular mechanism underlying 
reward and addiction involves alterations in D1DR localization. Cellular mechanisms of 
desensitization include internalization of the receptor through complex receptor 
dynamics. The overall hypothesis for this dissertation was that dopamine and acute 
ethanol exposure will cause the internalization of D1DRs. This hypothesis was tested 
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using virally transfected D1DRs tagged with eGFP which were localized using MPLSM 
in explants containing the mesolimbic pathway. The aims of this dissertation included:  
1. Development of virally transfection of eGFP tagged D1DRs. This specific 
aim was designed for the subcloning of a pseudovirus to induce the 
expression of eGFP-D1DRs. Briefly, the virus was produced through 
several steps with the major steps listed herein. The DNA encoding the 
eGFP-D1DR was obtained from Dr. Zhou (University of California, 
Irvine). This construct was inserted into the sindbis virus vector. RNA 
from two vectors, one encoding the sindbis nonstructural proteins (and 
gene of interest) and a second vector encoding viral structural proteins, 
were electroporated into baby hamster kidney (BHK) cells to produce 
sindbis pseudovirions.  
2. Characterization and expression of eGFP-D1DR through viral infection of 
parasagittal explants imaged using multi-photon excitation. This aim was 
designed to characterize the pseudovirus infectivity as well as the function 
of the virally transfected receptor. Additionally, the characterization of 
parasagittal explants and multi-photon excitation of eGFP in these 
explants was accomplished. eGFP-D1DR function was tested using cAMP 
production upon agonist and antagonist application. The development of a 
novel parasagittal explant containing the mesolimbic pathway required 
characterization to ascertain that dopaminergic neurons were present. 
Tyrosine hydroxylase (TH) staining confirmed dopaminergic cells were 
present in the appropriate areas. The methodology for viral delivery into 
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explants was established as well. In addition, optimal multi-photon 
excitation parameters for explant imaging were established. 
3. Test the hypothesis that dopamine and ethanol induce virally transfected 
eGFP-D1DR clustering and internalization detected in viable neurons of 
parasagittal explant using MPLSM. This aim was designed to investigate 
the localization of eGFP-D1DR by two-photon fluorescence excitation in 
viable neurons in the NAcc. D1DRs have been shown to internalize upon 
agonist-induced stimulation, but such internalization has never been 
shown in viable mammalian neurons. D1DRs are also hypothesized but 
have never been shown to internalize in response to ethanol. Therefore, 
dopamine and ethanol were used to stimulate eGFP-D1DRs, expressed by 
viral infection of cells in a parasagittal explants to test our hypothesis that 
D1DRs will cluster and internalize in response to these stimulations.  
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Chapter 2: Subcloning eGFP- D1DR into the Sindbis Expression System 
2-1. OVERVIEW 
The production of the eGFP-D1DR sindbis virus is described in this section. Additional 
details (such as recipes) and commonly used protocols are provided in Appendix I and II, 
respectively; however, enzymatic reactions that were required are included in this 
chapter. The DNA containing eGFP-D1DR was ligated into the pSinRep5 vector. Both 
the subcloned pSinRep5 vector and the defective helper DH(26)S vector (which encodes 
the structural proteins of the virus) were linearized and transcribed into RNA by in vitro 
transcription. These RNA preparations were then electroporated into baby hamster 
kidney (BHK) cells, used as hosts to make virions. The virions were then collected from 
the media and concentrated by discontinuous gradient ultracentrifugation. 
2-2. Vector Propagation 
A kanamycin resistant DNA vector (based in the pEGFP-N1 vector, Clontech, Palo Alto, 
CA, exact sequence unknown) containing the eGFP-D1DR sequence (the Rattus 
norvegicus dopamine-1A receptor with eGFP fused to the carboxyl tail) was provided by 
the lab of Dr. Q. Zhou at the University of California at Irvine (Bermak et al., 2002). The 
sindbis vectors (pSinRep5 and DH(26)S) are both ampicillin resistant (see Table 1-1,2 for 
more information on vectors). Separate kanamycin- and ampicillin-containing agarose 
plates were prepared for the purposes of quick transformation (Recipe R1 in 
Appendices). A quick transformation utilized heat shock so that bacteria would 
endocytose the DNA vectors; bacterial colonies that have incorporated these vectors were 
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propagated on antibiotic agarose plates since these vectors contain the appropriate 
antibiotic resistant gene.  
2-2.1. Quick Transformation  
Approximately 10 ng of each vector was transformed at 40 °C for one minute into 10 uL 
Epicurean coli XL-1 Blue cells (Stratagene, La Jolla, CA). Media (100 uL SOC media) 
was added to transformed bacteria. Aliquots (25 uL and 75 uL) of transformed bacteria 
were plated on kanamycin or ampicillin/luria broth base (LB) plates which were 
incubated overnight at 37 °C. A single colony from each plate was propagated in LB 
broth containing kanamycin or ampicillin (depending on the vector) at 37 °C with 
shaking at 225 rpm overnight; the resultant plasmid DNA was then extracted as described 
below.  
2-2.2. Plasmid DNA-Purification 
Plasmid DNA from the overnight culture was extracted using a Qiagen Plasmid Maxi Kit 
(Qiagen, Valencia, CA). The broth from the overnight culture was poured into a 50 mL 
conical centrifuge tube and the cells pelleted by centrifugation (6,000 x g for 15 minutes 
at 4 °C). The supernatant was discarded and the pellet was fully re-suspended in 10 mL 
of P1, the cell resuspension buffer (with RNase added). The cells were lysed by adding 
10 mL of P2 lysis buffer and the container was gently inverted five times and incubated 
for 5 minutes at room temperature. At this step the bacteria were lysed and the fluid was 
handled gently to avoid shearing genomic DNA. Then, chilled P3 neutralizing buffer (10 
mL) was added and gently mixed by inverting the container five times, causing the 
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precipitation of the genomic material. This mixture was immediately transferred into a 
QIA filter cartridge and incubated for 10 minutes at room temperature. During the 
incubation, the Qiagentip was prepared with 10 mL of QBT buffer. The Qiagentip and 
the Qiagen filter cartridge were than assembled and the genomic material was applied to 
the column (assisted by a plunger). Once the genomic material had fully entered the 
column, 60 mL of QC wash buffer was added. The DNA was eluted with 15 mL of QF 
buffer and collected in a 30 mL tube. The DNA was next precipitated by adding 10.5 mL 
of room temperature isopropanol to the 30 mL tube, which was immediately mixed and 
centrifuged at 15,000 x g for 30 minutes at 4 °C. A small transparent pellet formed, and 
the supernatant was carefully discarded. This pellet was washed with 70% ethanol by 
rolling it over the pellet in the tube, and the mixture was centrifuged again at 15,000 x g 
for 10 minutes followed by pellet isolation. The tube was inverted and the pellet was air 
dried for 10 minutes. The pellet was fully dissolved in 0.5-1.0 mL of nuclease-free H2O. 
A nanodrop UV spectrometer (Nanodrop Technologies, Wilmington, DE) was used to 
analyze 1 uL of the resulting DNA solution for concentration and quality measurements. 
2-3. PREPARATION OF EGFP-D1DR DNA FOR PSINREP5 LIGATION  
2-3.1. Obtaining the Appropriate DNA for Ligation 
The DNA needed for ligation was excised from the Zhou vector and subcloned into the 
pSinRep5 vector. The pSinRep5 vector was linearized by cleaving the vector with the 
restriction enzyme Pml I, a ligation point located near the middle of the insertion of the 
gene of interest sites. The Zhou vector was cleaved using both restriction enzymes Not I 
and Hind III to release an insert containing eGFP-D1DR. 
 
The following reactions were incubated for 3 hours at 37 °C:  
pSinRep5    Zhou vector  
DNA:    5 ug   DNA:    5 ug 
BSA:    1 uL   BSA:    1 uL 
Buffer 1:  10 uL   Buffer C:  10 uL 
Pml I:    4 uL   Not I:    4 uL 
     Hind III:   4 uL 
Nuc. free H20: balance   Nuc. free H20: balance 
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vector and the eGFP-D1DR insert (Figure 2-1) were excised from the gel, placed in 1.5 
mL tubes and weighed. Using the “rapid gel extraction” protocol (from Gibco BRL Life 
Technologies Concert Rapid PCR Extraction System, Invitrogen, Carlsbad, CA), the 
DNA of appropriate size was extracted from the gel. For every 10 mg of gel, 30 uL of gel 
solubilizing buffer (L1) was added and the preparation then incubated at 50 °C. Every 3 
minutes the tube was shaken, and after the gel was dissolved, a final 5 minute incubation 
was performed. This mixture was pipetted into a spin cartridge, placed in a 2 mL wash 
tube, and centrifuged at 12,000 x g for 1 minute at room temperature. The supernatant 
was discarded. The cartridge, which contained the DNA of appropriate size bound to the 
column, was returned to the wash tube and 700 uL of wash solution (H2) was added and 
incubated for 5 minutes at room temperature. The cartridge and tube were centrifuged for 
12,000 x g for 1 minute at room temperature. The supernatant was discarded, and an 
additional 1 minute spin was conducted to clear all the supernatant. The spin cartridge 
was then placed in a 1.5 mL tube, and DNA was eluted with 30 uL of 50 °C nuclease-free 
H2O and incubated at room temperature for 5 minutes. The cartridge and tube were then 
centrifuged at 12,000 x g for 2 minutes. 
2-3.2. Preparation of Appropriate DNA for Ligation 
The DNA of both the insert and the pSinRep5 vector were treated for better ligation 
probability. The linearized pSinRep5 was dephosphorylated to reduce the probability of 
recombination of the vector without the eGFP-D1DR insert. The cleaved ends of 
pSinRep5 were dephosphorylated by treatment with alkaline phosphatase from calf 
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intestine. The eGFP-D1DR was prepared with an end-filling polymerase (klenow DNA 
polymerase) in order that the insert had blunt ends for ligation with the pSinRep5 vector. 
linearized pSinRep5 DNA:30 uL  insert eGFP-D1DR DNA: 15 uL 
10X CIP Buffer:         5 uL  10X Klenow Buffer :         5 uL 
Nuc. free H20        10 uL  Nuc. free H20        26 uL 
CIP enzyme          5 uL  Klenow enzyme          1 uL 
10X  dATP          1 uL  
10X dGTP          1 uL 
10X dCTP          1 uL 
10X d TTP          1 uL 
 37 °C 15 minutes    37 °C 15 minutes 
 added 1 uL CIP enzyme   75 °C 10 minutes  
  55 °C 45 minutes 
 0.5 uL of 500 mM EDTA 
 75 °C 10 minutes 
     
2-3.3. DNA Isolation 
Phenol/chloroform extraction was used to isolate DNA for ligation. Both reactions from 
the previous section had 50 uL of nuclease-free H20 added so that each reaction had a 
total volume of 100 uL. Phenol was added in equal volumes to each reaction (100 uL). 
These samples were mixed and centrifuged at 12,000 x g for 1 min. The DNA in the 
upper aqueous layer was carefully transferred to a fresh tube, and the organic lower layer 
containing protein was discarded.  The aqueous layer was again extracted from an equal 
volume of chloroform after the sample was centrifuged at 12,000 x g for 1 minute. The 
DNA was precipitated by adding one tenth the volume (1/10x) of 3M sodium acetate 
(~10 uL) and twice the volume (2x) of 100% ethanol (~200 uL). These samples were 
placed in a -80 °C freezer for 2 hours and were then centrifuged at 12,000 x g for 15 
minutes at 4 °C. The supernatant was discarded, the pellets allowed to air dry, and 15 uL 
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of nuclease-free H20 was used to resuspend the pellets and incubated at room temperature 
for 10 minutes.  
2-3.4. Ligation 
The eGFP-D1DR insert and the linearized pSinRep5 vector were ligated in a 1:1 molar 
ratio with T4 DNA ligase in an overnight reaction at 4 °C. The pSinRep5 vector was 
twice the concentration of the insert at this step since twice the volume was used to 
dephosphorylate vector DNA than was used for end filling of the insert DNA.  
pSinRep5 vector DNA: 2 uL 
eGFP-D1DR insert DNA: 1 uL 
2x ligase buffer:  2.5 uL 
T4 DNA ligase   1 uL 
Nuc. free H2O  1 uL 
      4 °C overnight  
2-3.5. Slow Transformation of Ligation 
After ligation, a slow transformation was performed as the DNA was fragile at this 
juncture.  The DNA of the ligated vector (5 uL) was mixed with 50 uL of Epicurean coli 
XL1-Blue (never thawed) and incubated on ice for 30 minutes. The DNA was 
transformed with a heat shock at 42 °C for one minute. Media (450 uL SOC) was added 
and the resulting mixture incubated for 45 minutes at 37 °C. An aliquot of 100 uL was 
plated on an ampicillin/LB plate. The remaining cell mixture was centrifuged at 12,000 x 
g for 1 minute. Supernatant (200 uL) was discarded and the remaining supernatant and 
resulting pellet were re-suspended and plated on an ampicillin/LB plate and incubated 
overnight at 37 °C. 
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Individual colonies (8) were selected from the ampicillin/LB plates and mass produced in 
broth media. This number was chosen to ensure several colonies of the proper orientation 
of eGFP-D1DR in pSinRep5. Approximately half of those colonies should represent the 
proper orientation of the eGFP-D1DR insert in pSinRep5 while the other half will have 
the insert in the reverse orientation in pSinRep5. There was also a third possibility, that 
no insert may be present in some colonies as self-ligation of the pSinRep5 vector was 
possible even with dephosphorylation of the vector. LB broth (3 mL) and ampicillin (3 
uL) were put into 8 tubes and inoculated with a 20 uL pipette tip that had touched an 
individual colony. Of these 8 tubes, 7 grew bacteria. DNA was harvested from those 7 
tubes by Qiagen Plasmid Miniprep. 
2-3.6. Plasmid DNA Purification 
Qiagen spin Minipreps were used for smaller volume and quantity of bacterial 
production. The seven tubes were spun at 12,000 x g for 5 minutes at 4 °C. The 
supernatant was discarded and the pellet was re-suspended in 250 uL of P1 buffer. This 
solution was then transferred into a 1.5 mL microfuge tube. Buffer P2 (250 uL) was 
added and the tubes inverted gently 5 times. Next Buffer N3 (350 uL) was added and the 
tubes inverted gently 5 times. These tubes were then centrifuged at 12,000 x g for 10 
minutes. During centrifugation a QIAprep spin column was placed in a 2 mL collection 
tube. The supernatant was then applied to the QIAprep spin column by decanting. The 
supernatant was centrifuged for 1 minute at 12,000 x g, and flow through of the column 
discarded. The column was washed with 0.75 mL of PE buffer and centrifuged for 1 
minute at 12,000 x g, and the wash through was discarded. An additional 1 minute at 
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12,000 x g centrifugation was done to remove all wash buffer. The QIAprep spin column 
was then placed into a clean 1.5 mL tube. The DNA was eluted with 50 uL of nuclease- 
free H2O by pipetting into the center of each column and incubating for 2 minutes at 
room temperature. The column and tube were centrifuged for 1 minute at 12,000 x g. 
These solutions were analyzed with a nanodrop UV spectrometer to determine quality 
and quantity of genomic material. 
2-3.7. Verification of the Correct Orientation of eGFP-D1DR in pSinRep5 
The restriction enzyme Cla I was used to cleave each harvested transformation to identify 
the ligation orientation. DNA (1 ug) was incubated with 2 uL of Cla I, 1 uL of BSA, and 
2.5 uL of Cla I buffer in a final volume of 25 uL for 1 hour at 37 °C. The ligations were 
also compared to pSinRep5 (without eGFP-D1DR) cleaved with Cla I, and the cleaved 
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Figure 2-2. Cla I digestions of ligations of pSinRep5 and eGFP-D1DR. The proper 
orientation was determined by sequencing. The ligations with resulting fragments that 
were similar to the middle well had a sequence corresponding to a dopamine receptor. 
 
The resulting cleavage differences were grouped as two unknown insert orientation 
groups and one no insert group (Figure 2-2). Two examples from the unknown 
orientation group were sequenced using primers directed at the ligation area of pSinRep5. 
Primers were ordered from IDT (Coralsville, IA): (pSinRep5 primer forward: 
5’AGCATAG TACATTTCAT CTG-3’). The primer tubes were centrifuged briefly 
before opening and 100 uL of nuclease-free H2O was added. This was further diluted 
1:10, and 1 uL of this diluted primer was used for sequencing. For the sequencing 
reaction, 700-1000 ng of the DNA was added to about 6 pmol of primer in nuclease-free 
H2O with a final volume of 11-12 uL. These samples were then analyzed by the DNA 
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Sequencing Core Facility at the University of Texas at Austin Institute for Cellular and 
Molecular Biology. The resultant sequence (shown following) showed a significant 
match with “Rattus norvegicus Dopamine-1A receptor (Drd1a),” a D1DR as 
authenticated by the National Center for Biotechnology Information website 
http://www.ncbi.nlm.nih.gov/. The sequence match was verified by performing a 






















2-4. PRODUCTION OF SINDBIS EGFP-D1DR 
2-4.1. Propagation of New eGFP-D1DR Containing pSinRep5 Vectors  
The ligations containing eGFP-D1DR were propagated as described above with quick 
transformations and purified with Qiagen maxi-preps. 
2-4.2. in vitro Transcription of Sindbis eGFP-D1DR viral DNA 
Both DH(26)S, the viral structural gene vector, and pSinRep5 containing the eGFP-
D1DR construct were linearized using the restriction enzyme Xho I.  DNA (5.0 ng) was 
added to 1 uL of BSA, 10 uL of Xho I buffer, and 5 uL of XhoI enzyme with nuclease-
free H2O making up the balance for a final volume of 100 uL and incubated at 37 °C for 
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3 hours. These reactions were checked for complete cleavage by agarose gel 
electrophoresis using uncut vectors as a control. 
 
Protease K (1 uL) was added to inactivate any remaining restriction enzymes (37 °C for 
30 minutes). Then a phenol:chloroform extraction was completed to isolate the DNA as 
described previously. The precipitated DNA was dissolved in 4 uL of DEPC-treated H2O. 
The tube was incubated at room temperature for 10 minutes for full resolubilization. The 
following reactions then were completed in small PCR tubes (all solutions were included 
in the Ambion SP6 in vitro transcription kit (Ambion, Austin, TX): 
  4 uL of DNA in DEPC H2O 
10 uL of 2x NTP/Cap 
  2 uL 10x Reaction Buffer 
  2 uL Enzyme Mix 
  1 uL GTP 
 
 
Reactions were incubated at 37 °C for 1 hour. Then an additional 1 uL of enzyme mix 
was added followed by one additional hour incubation at 37 °C. RNA was isolated by 
phenol:chloroform extraction as previously described for DNA, and the RNA pellets 
were dissolved in 20 uL of DEPC H2O (see Protocol P1 in Appendices for step by step 
instruction). 
2-4.3. Analysis of Sindbis RNA  
Gel electrophoresis of the RNA was performed (Figure 2-3) and analyzed by ultraviolet 
spectrometry using the nanodrop UV spectrometer for quality and quantity 
measurements. Great care was taken to avoid contamination by RNases. The gel box and 
attachments were soaked in ~3N HCl for 15-30 minutes and then rinsed with RNase-free 
TBE. All RNase-free solutions were prepared using DEPC H2O. A 0.7% agarose gel in 
TBE with 90 ug/uL of ethidium bromide was prepared. Gel electrophoresis was 































re 2-3. Gel displaying two samples of RNA made by in vitro transcription from 
Rep5 ligated with eGFP-D1DR. 
. Electroporation of Sindbis RNA 
 cells were grown in five 175 cm2 flasks at a passage cycle below 75. The media 
removed and the cells washed with 10 mL RNase-free PBS without cations at room 
erature. Each flask was treated individually with 3 mL of 0.25% trypsin until cells 
 freely floating without forming clumps. Trypsinization was halted with 5 mL of 
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10% fetal bovine serum (FBS) in minimum essential medium (MEM). This mixture was 
transferred to 15 mL sterile tubes and centrifuged for 5 minutes at 500 rpm at room 
temperature. Cells were washed by re-suspending in 5 mL ice cold RNase-free PBS 
without cations. Re-suspension was by gentle inversion repeated fifty times. The re-
suspension was then centrifuged for 5 minutes at 500 rpm at room temperature. This 
wash was repeated by gently re-suspending the cells in 5 mL ice cold RNase-free PBS 
without cations and centrifuged for 5 minutes at 500 rpm at room temperature. A small 
aliquot of the cells was taken and the total number of cells was determined by using the 
Hemacytometer equation:  
(Hemacytometer average) x (104 ) x (volume of cells) = total number of cells.  
A third RNase-free PBS wash and centrifugation was followed by the re-suspension of 
cells at a density of 1.5 x107 cells/mL in ice cold RNase-free PBS without cations. The 
final electroporation mixture contained in ice cold 1.5 mL eppendorf tubes was: 500 uL 
of BHK cells and 10-15 ug each of RNA for both the DH(26)S and pSinRep5 eGFP-
D1DR. This mixture was transferred to ice cold cuvettes and electroporated twice as 
follows: 
BioradGene Pulsar with Pulse Controller 
0.2 mm electrode gap cuvettes from biorad 
1.5 kV, 25 uFD, resistance=infinity 
time constant should result in 0.7 msec 
 
 
After electroporation the cuvettes were incubated at room temperature for 10 min. With a 
sterile glass pipette the solution was removed and 9.5 mL of MEM with 10% FBS was 
gently mixed with electroporated BHK cells by inversion. Then 2 mL of combined media 
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and electroporated cells were placed into five 35 mm dishes and incubated at 37 °C in a 
standard cell culture incubator containing 5% CO2. Successful electroporation of BHK 
cells was verified by fluorescence detection after 24-60 hours. Media was collected daily 




Figure 2-4. Electroporated baby hamster kidney cells. A) Fluorescent image 
illustrating the production of eGFP. B) Light image showing cells present after 





2-4.5. Sindbis Viral Stock Concentration 
The media collected from electroporated BHK cells was concentrated by 
ultracentrifugation through a discontinuous sucrose gradient. All solutions were kept 
sterile for later infection of sterile cells. In ultracentrifuge tubes 1 mL of 55% sucrose in 
TNE buffer (see Recipes R6 and R7 in Appendix I) formed the gradient base. A 3 mL 
layer of 20% sucrose in TNE buffer was placed over the 55% sucrose layer. Finally 6 mL 
of culture media from electroporated BHK cells was layered over the 20% sucrose. These 
tubes were carefully balanced with the swinging portions of an ultracentrifuge rotor (CA 
SW-41Ti, Beckman Coulter, Inc, Fullerton) and were ultracentrifuged (Optima XL-100K 
Ultracentrifuge, Beckman Coulter, Inc, Fullerton, CA) for 90 minutes at 30,000 rpm 
(160,000 x g). The top layer (8 mL) was carefully aspirated and discarded (after 
autoclaving in case of virion contamination). The 1 mL layer above the interface, which 
contained purified virions, was collected, aliquoted and stored at -80 °C. The final 1 mL 
fraction was also discarded after autoclaving in case of viral contamination. 
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Chapter 3: Sindbis Viral Mediated Expression of eGFP-D1DR in 
Parasagittal Explants with Multi-photon Laser Scanning Microscopy 
3-1. OVERVIEW 
Many aspects of this dissertation project were novel for our laboratory, making an initial 
characterization of: eGFP-D1DR sindbis virus, parasagittal explant and MPLSM 
necessary. For example, fluorescence following electroporation of BHK cells with eGFP-
D1DR pSinRep5 and DH(26)S RNA indicated that eGFP was expressed, but no direct 
evidence that virions were made or that the D1DR was functional was provided. 
Therefore, the viral transfection system was characterized for its ability to produce 
functional D1DRs. The neuronal model used for imaging experiments was the 
parasagittal brain slice culture, or organotypic explant, which also required 
characterization to ascertain the presence of dopaminergic cells emanating from the VTA. 
To accomplish this, explants were stained by immunohistochemistry for the presence of 
TH. Finally, the MPLSM had to be characterized for the fluorophore eGFP and 
customized for explant imaging.  
3-2. CHARACTERIZATION OF VIRAL EXPRESSION SYSTEM 
3-2.1. Transfection of Neurons 
To ascertain that virions were produced in BHK cells and released into the culture media, 
the media was collected and tested for its ability to infect other cells. Supplementary 
infection indicates that both of the sindbis expression system vectors were expressed and 
that virions were formed. Primary cultured neurons, slice cultures, and in vivo neurons 
were all used to demonstrate functional virion production. Primary cultures were infected 
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by direct addition of concentrated virus to the media (~ 30 uL/2 mL). Slice cultures were 
infected in a novel manner with concentrated virus injected under the surface of the slice 
culture using a glass capillary and delivered with a manual positive displacement 
microdispenser (VWR, West Chester, PA; capacity 10 uL). Glass capillaries for this 
dispenser were formed similar to patch electrodes, loaded with approximately 3-5 uL of 
the concentrated viral preparation, and used to infect explants at multiple points using 50-
100 nL per injection. Mice were infected in vivo using the Small Animal Stereotaxic 
Instrument Model SAS75 (Cartesian Research, Inc.). Concentrated virus was delivered to 
the NAcc (AP +1.7, LAT +0.8, DV – 2.0) using a syringe pump (500-1000 nL over one 
minute). 
 
The ability of the sindbis virus system to induce expression of eGFP-D1DR (as presumed 
by fluorescence emission) was verified by two-photon excitation in primary dissociated 
neuronal cultures, slice cultures, and slices following in vivo infection. We first observed 
expression of eGFP-D1DR in dissociated neurons from the ventral striatum (Figure 3-
1A). The eGFP-D1DR expression was distributed extensively throughout the neuron, 
including the cell body and in the processes, including dendrites, as well as their well-
known spiny protrusions (inset). Fluorescence of cultured dissociated cells was 
monitored via two-photon excitation approximately 1-3 days post-infection. Next, viral 
infection was assessed in parasagittal slice cultures that included the NAcc. Despite the 
difference in the method of infection in slice cultures (local injection) compared to 
dissociated cultured neurons (simple addition of virus to media), the time course of viral 
expression appeared to be similar. Expression 3 days post-infection in slice cultures is 
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shown in Figure 3-1B. Finally, viral infection was tested in vivo following local injection 
into mouse NAcc. In vivo infection also displayed a similar time frame for expression. 
Fluorescent cells along the injection tract were apparent three days post-infection (Figure 
3-1C). Slices imaged prior to three days post- infection resulted in little or no detectable 
infection as measured by fluorescence. The ability of this virus to cause infection in many 
different neuronal models underscores the advantage of viral infection for successful 
gene expression in neurons. 
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Figure 3-1. Viable neurons expressing eGFP-D1DR after infection with the sindbis 
virus. A) Ventral striatal dissociated cell infected with the eGFP-D1DR sindbis virus. 
This culture was 34 days in vitro and had been infected for 5 days. B) Fluorescence of 
cells in infected slice. This slice was infected using 4 injections of 100 nl virus and 
imaged 3 days later. C) In vivo infection. Virus (500 nL) was delivered into the NAcc 
(1.7 AP, 0.8 LAT, -2.0 DV) using a micropump. Slices were made and viewed 3 days 
after infusion.  
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3-2.2. Viral Titer 
The sindbis expression system produces a suicide pseudovirion, so named because each 
virion can only infect once. The lack of genetic information encoding structural genes 
(since the helper vector is not repackaged) prevents viral replication, thereby making the 
conventional viral titer procedure of plaque formation inappropriate for viral 
characterization. Instead, infection by the sindbis expression system is determined more 
empirically by the number of infected cells using viral dilutions to determine the number 
of colony forming units per volume of concentrated viral stock. 
 
BHK cells were infected with different dilutions of virus to calculate viral titer. First, 
BHK cells were grown to 80% confluency in 175 cm2 flasks; these cells were then 
detached with 3 mL of trypsin. Trypsinization was halted with 10 mL of MEMcontaining 
10% FBS. An aliquot (10 uL) of dissociated cell preparation was taken for cytometry (see 
Appendix II Protocol P2 for equation). The preparation was then diluted to 0.5-1.0 x 10 5 
cells/mL. In a 6 chambered coverglass, 1 mL of diluted cells was dispensed in each 
chamber and then placed in a 37°C incubator for approximately 24 hours to allow cell 
attachment. The following day, six serial dilutions of virus were made at 1:10 each. Cells 
were infected as follows: one chamber received 90 uL of concentrated virus then 
subsequent chambers received 90 uL of each of the six progressive 1:10 serial dilutions, 
leaving an uninfected chamber for control. These cells were returned to the incubator at 
37 °C for 24 hours. The titer was determined to be approximately 2 x 106 cfu/mL (colony 
forming units per mL). This was determined by counting the number of fluorescent cells 
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(2) present in the most dilute virus (106) that established infection. This titer was greater 
than other sindbis viral stocks that had not been concentrated and is a typical titer for 
viral stocks used in subsequent experiments. 
3-2.3. eGFP-D1DR function 
To determine if the D1DRs expressed by cells infected with the virus were functional, 
cAMP assays were performed (Assay Designs Inc. Cat # 900-066, Ann Arbor, MI). BHK 
cells were plated (~1.5 X 105 cells/well) in a 24 well dish. Approximately 18 hours later, 
wells were infected with 10 uL of concentrated sindbis virus expressing eGFP-D1DR to 
induce a high level of infection. Cultures were inspected by confocal imaging for 
infection 24 hours later, with approximately 90% of cells showing fluorescence. The cells 
were then treated with D1DR agonists and/or antagonists for 1 hour at 37°C. Cells were 
lysed with a combination of 0.1 M HCl and ultrasonication (Fischer Scientific Sonic 
Dismembrator Model 100). Samples were treated in triplicate and cAMP production was 
detected as per instructions of Direct cAMP kit. Absorbance was measured at 405 nm on 
a FL600 microplate reader (BioTek, Winooski, Vermont). 
 
Cyclic AMP was measured in BHK cells that infected with a sindbis virus that induces 
the expression of eGFP-D1DR and in uninfected BHK cells. Cells were challenged with 
dopamine alone or in combination with the selective D1DR antagonist, SCH 23390 
(Figure 3-2). Infected cells responded to dopamine challenge in a dose-related manner 
while control cells displayed no sensitivity to dopamine (Figure 3-2A). The ability of 
dopamine to stimulate cAMP production was antagonized by the D1DR antagonist SCH 
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23390 in a concentration-dependent manner (Figure 3-2B). Wildtype mammalian D1DRs 
have an affinity of 10-18 uM dopamine for the low affinity conformation of the receptor 
(for review see Neve and Neve, 1997). Although a comprehensive dose response curve of 
the virally-induced eGFP-D1DR was not completed, the EC50 for dopamine was within 
that range. For SCH 23390, the EC50 was approximately 1 nM. Maximum cAMP 
production in response to dopamine (1,000 uM) was 70 ± 0.7 pmol/mL in infected cells 
compared to only 3 ± 0.6 pmol/mL in uninfected cells. SCH 23390 (0 nM) plus dopamine 
(10 uM) resulted in maximal cAMP production of 50 pmol/mL ± 0.6 were within the 

























































Figure 3-2. Cyclic AMP production demonstrates expression of functional D1DRs. 
A). Dopamine-stimulated cAMP response in virally-infected and uninfected BHK cells. 
B) Dopamine (10 uM) stimulated cAMP production in infected BHK cells treated with 
the dopamine antagonist SCH 23390. 
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3-3. PARASAGITTAL MESOLIMBIC EXPLANT CHARACTERIZATION 
3-3.1. Explant Introduction 
The first explants, or organotypic slice cultures, were prepared in 1956 by the roller tube 
method using non-neuronal tissue (Ehrmann and Gey, 1956). This method involved 
tissue fastened to a glass coverslip inside a capped tube that rotates for delivery of media 
without the tissue being constantly submerged. In 1981, a very similar technique was 
applied to hippocampal and other neuronal tissue (Gahwiler, 1981). Neuronal explants 
retain many of the connections present in the brain while the in vitro model of dissociated 
neuronal cell cultures has only random connections. In 1991, a less labor-intensive and 
less time-consuming method of explanting neuronal tissue was introduced that uses a 
semi-permeable membrane culture dish insert (Stoppini et al., 1991). With this method, 
acute slices of neuronal tissue can be easily produced and maintained in incubators. This 
viable tissue preparation still has intact neuronal connections. There are other advantages 
to organotypic slice cultures, including the ease of delivery of virally-transfected 
receptors. Moreover, Shi et al. (1999) showed differential expression of receptors on the 
cell surface between dissociated cultured hippocampal neurons and hippocampal 
explants. Therefore, trafficking studies that utilize explants may offer a more 




Parasagittal explants that include the mesolimbic pathway provide a physiological system 
for studying neuroadaptive changes caused by drugs of abuse which are known to affect 
this area. These explants contain critical mesolimbic areas, including the VTA, NAcc, 
prefrontal cortex, and hippocampus that would facilitate study of the neurobiology of 
reward and abuse. Increased dopamine in the mesolimbic pathway appears to be 
important in the rewarding effects of drugs of abuse such as ethanol. Parasagittal 
explants, used in this dissertation project, thus offer a viable model for studying ethanol’s 






Figure 3-3. Approximate parasagittal plane used to make explants. This plate is 
altered from the Paxinos & Watson rat brain atlas (coordinate plate 80). The mesolimbic 
dopamine pathway initiating in the Ventral Tegmental Area (VTA) and terminating in the 
Nucleus Accumbens (NAcc) are included, as well as other areas implicated in addiction 
such as the Prefrontal Cortex (PFC) and the Hippocampus (HC). 
HC
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3-3.2. Explant Methods 
Parasagittal mesolimbic brain slice explants were prepared from Sprague Dawley rat 
pups (4-7 days old, University of Texas at Austin Animal Resource Center) under 
IACUC guidelines. The brain was removed quickly and placed in ice-cold cutting 
artificial cerebrospinal fluid (aCSF, in (mM): NaCl, (120); KCl, (3.3); NaH2PO4, (1.23); 
NaHCO3, (25); CaCl2, (2.0); MgSO4, (0.9); dextrose, (10) and continuously gassed with 
95% O2/ 5% CO2 (pH 7.2, 280-290 mOsm, 32 °C) for 2 minutes. The brain was then 
mounted on the stage of a vibrating slicer containing a Peltier temperature controller 
(World Precision Instruments, Sarasota, FL), and 500 um parasagittal slices were cut as 
in Figure 3-3. Slices containing the VTA and NAcc were incubated in cutting aCSF for 
approximately 40 minutes. Slices were then placed on 30 mm Millipore (Billerica, MA) 
CM membrane inserts housed in six well plates containing 1.2 mL per well of HEPES-
buffered media (75% MEM, 25% heat activated horse serum, 3mM L-glutamine, 100 
U/mL penicillin/streptomycin, and 5.5 mg/mL dextrose). Explants were incubated in 5% 
CO2 at 37°C, and media was changed 24 hours after explanting and then subsequently 
every 48 hours. These explants were fully transformed into cultures and became 
translucent or “cleared” after 7- 10 days in vitro. 
3-3.3. Tyrosine Hydroxylase Immunohistochemistry of Explants 
Staining for TH was performed with a polyclonal rabbit anti-TH antibody (Chemicon 
International, Temecula, CA) and a secondary 3-3'-diaminobenzidine tetrahydrochloride 
(DAB) staining kit for rabbit antibodies (Santa Cruz Biotechnology, Inc, Santa Cruz, 
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CA). Explants were rinsed with PBS to remove all media. Fixation of the explant on the 
membrane insert was completed after a 1-4 hour incubation at room temperature with 4% 
paraformaldehyde and 0.12 M sucrose. The explants were then incubated in 0.1 M 
glycine in PBS overnight at 4 °C and were carefully removed from the insert membrane 
using a cell harvester and a precision sable brush. The slice was permeabilized with the 
detergent triton (0.2% in PBS) at 4 °C overnight. The following day, explants were 
incubated in 10% goat serum for 1 hour at room temperature on an oscillating shaker at 
70 rpm. The explants were washed three times with 0.2% triton in PBS for 10 minutes at 
70 rpm. Then the slice was incubated for 48 hours at 4 °C in primary antibody dilutions 
of 1:1000 in 0.2% triton containing 2.8% goat serum and washed three times in 0.2% 
triton in PBS as before. During these washes, the AB enzyme reagent was prepared 30 
minutes before use. Reagent A (avidin, 50 uL) was added to reagent B (biotinylated 
horseradish peroxidase, 50 uL) in 2.5 mL of PBS. The tissue was incubated at room 
temperature for 1 hour in this AB reagent. Explants were again rinsed three times for 10 
minutes in 0.2% triton in PBS. Distilled H2O (1.6 mL) was then combined with 5 drops 
of 10x substrate buffer, 1 drop of 50x DAB chromogen, and 1 drop of 50x peroxidase 
substrate. Explants were incubated in this solution for approximately 40 seconds and then 
rinsed with PBS. Processed explants were mounted on gelatin-subbed slides and allowed 
to dry at 4°C before cover slips were attached.  
 
Figure 3-4 shows examples of cells in the parasagittal explant that are positive for the 
enzyme TH. The presence of projecting TH positive dopaminergic cells in the 
appropriate brain regions suggests an intact mesolimbic pathway in the parasagittal 
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explant. All the explants from the immunocytochemistry experiments contained cell 
bodies that were positive for TH. Additionally, 85% of explants had staining in the 
ventral striatum which contains the NAcc. The remaining 15% were explants that were 
damaged during the staining process, and the ventral striatum could not be distinguished. 
Figure 3-4A shows a single cell with long projections toward the NAcc. Figure 3-4B is a 
low power magnification of the midbrain of an explant with many cells positive for TH in 
the area of the VTA. Although TH staining is seen in the ventral striatum and in the 
midbrain of these explants, it does not prove that dopaminergic cells and projections are 






























ure 3-4. Tyrosine Hydroxylase (TH) immunohistochemically stained explants 
mplifying the presence of dopaminergic cells in parasagittal explants. A) A single 
 positive cell with its characteristic projecting processes. B) Low magnification of the 
brain of a TH stained explant shows many cells positive for TH in an area which 




3-4. MULTI-PHOTON LASER SCANNING MICROSCOPE PARAMETERS AND 
DETECTION OF EGFP FLUORESCENCE 
The use of positive controls was invaluable for characterizing the MPLSM. Brain slices 
of transgenic mice with the S100 promoter coupled to GFP were fixed and placed on 
slides (kindly provided by Dr. Wes Thompson, University of Texas at Austin). They 
provided ideal positive controls, as a strong signal was always available and bleaching 
did not appear to be a factor. These slides were used to empirically determine the proper 
wavelength to excite eGFP to study laser power versus fluorescence emission 
phenomena, and for daily laser alignment of the detectors. 
 
The bioluminescence marker GFP was first cloned from the jellyfish Aequorea Victoria 
in 1992 (Prasher et al., 1992). GFP is comprised of 238 amino acids. eGFP was generated 
following random mutations at the Ser-Tyr-Gly sequence at amino acids 65-67, and 
fluorescence-activated cell sorting established variants that were 35-times more 
fluorescently intense than wildtype GFP. Codon optimization also allowed for greater 
expression in mammalian cells, and codon optimization together with random mutation 
amplified fluorescence intensity by 100-fold compared to wildtype GFP (Cormack et al., 
1996; Zhang et al., 1996a). A reduction in bleaching is also a molecular characteristic of 
eGFP; a beta-can molecular structure surrounds the fluorophore,, protecting it from 
reactive agents that cause bleaching (Yang et al., 1996). GFP and its variants are widely 
used, not only for protein localization, but as a marker for gene expression. 
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The laser/light path of the MPLSM was relatively simple. A Spectra-Physics (a division 
of the Newport Corp, Irvine, CA) Millenia 5W argon (532 nm) source was used as the 
constant wave laser pump. The pump laser powered the Spectra-Physics Tsunami 
titanium:sapphire laser which was tunable and has the ability to mode lock for multi-
photon excitation. Excitation power independent of wavelength and mode lock was 
controlled via a ½ wave plate and a polarizer used as a laser attenuator placed between 
the titanium:sapphire source and scanhead. Laser wavelength and mode status were 
observed through an Ocean Optics (Dunedin, FL) spectrometer. Mirrors directed the laser 
to the modified Olympus (Melville, NY) Fluoview scanhead. The scanhead was 
originally designed for confocal microscopy; therefore, the conversion to two-photon 
mode required removal of the neutral density filter and confocal aperture pinhole 
assemblies. Standard galvo-mirrors were retained; however, an infrared pupil transfer 
lens was supplanted for the standard optic. Since the laser was mode locked, it could not 
be launched efficiently via a fiber optic and must therefore be direct-launched. The laser 
was directed onto the stage of an upright brain slice Olympus (Melville, NY) BX-50W1 
microscope. eGFP emission was collected via the scanhead galvo-mirrors, filtered 
through a cuvette of CuSO4, and detected using standard Fluoview photomultiplier tubes. 
The focal plane of the objective was motorized and controlled by Fluoview software 
(version 2.0.32) using a fine focus z-motor for optical sectioning. The microscope stage 
was also motorized in the xy-plane for specimen alignment. This overall configuration 
was similar to other Olympus confocal microscopes that have been altered for MPLSM 
(Mainen et al., 1999; Majewska et al., 2000). 
 
The relationship between laser power and fluorescence emission is demonstrated in 
Figure 3-4. Detector settings and the wavelength were kept constant and only non-
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saturated emission levels were used for this power-emission assessment. Figure 3-4 
illustrates that as laser power increased, fluorescence emission also increased; however, 
multi-photon excitation is a non-linear fluorescence technique. The emission is 
quadratically related to the power of the laser. This is indicated by the log transformation 
of values and a resultant linear fit with a slope near two.  
 
When working with living cells, it is important to keep damage to a minimum. For this 
reason, a laser power of no more than 100 mW was used in these experiments, which 
resulted in a consistent fluorescence emission but did not cause cell death during the 
course of experiments. Electrophysiological studies in our lab also indicated that 
dissociated cultured neurons reliably survived dozens of sequential scans with a laser 
power of 100 mW (data not shown). Photodamage is decreased in multi-photon 
excitation as compared to confocal excitation; however, due to the greater laser 
intensities needed for multi-photon excitation, some cellular damage may occur 






























Figure 3-4. Log-log plot of laser power versus fluorescence emission. There is a strong 
linear relationship between log transformed laser power and log transformed fluorescence 
emission. With a resulting linear fit slope near two, the quadratic nature of multi-photon 
excitation and resultant fluorescence emission is observed. 
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The proper wavelength for optimal efficiency of eGFP excitation was also empirically 
determined. For this experiment, the power and detector settings were kept constant. As 
seen in Figure 3-5, a suitable wavelength for eGFP excitation was observed to be about 
845 nm; shorter wavelengths displayed greater autofluorescence levels, whereas 
wavelengths longer than 845 nm did not elicit strong two-photon excitation of eGFP. The 






































Figure 3-5. Wavelength of multi-photon laser versus the resulting fluorescence 
intensity as a percent of maximum.  
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The Olympus BX50WI microscope was equipped with a z-motor which functions in 
concert with Fluoview software and the multi-photon excitation laser to produce three-
dimensional representations of cells by optical sectioning. This optical sectioning allowed 
“stacks” of images to be acquired that encompass an entire cell. These stacks were 
required to compare cells for receptor localization with MPLSM. Stacks are a set of two 
dimensional images, with the difference between two adjacent images being of a known 
distance controlled by the z-motor. Multi-photon excitation occurs at a very restricted 
focal volume since the coincidence requirement for two photons to excite one electron is 
spatially restricted to a very small plane. Additionally, there was thermal and physical 
drift of viable cells in intact explants that require a three-dimensional image to be 
reconstructed for cell comparisons. One image acquired of a cell would not reliably 
encompass the entire cell, and subsequent images of the same cell (although programmed 
at the same focal plane) may not be of the same focal plane due to thermal and or 
vibrational movement-induced aberrations. Therefore, to image an entire cell in situ, cells 
were “bracketed” by z-sectioning and resulting two-dimensional images were analyzed 
subsequently for changes in fluorescence localization.  
 
The stacks were combined into a two-dimensional image (Figure 3-6) by aligning the 
brightest pixels from each image of the stack and combined into a three-dimensional 
representation (Figure 3-7), corresponding to the differences that occur between images 
in the stack by Metamorph imaging software (Universal Imaging Corporation, 
Downingtown, PA). Stacks rendered into two-dimensional images were quantified by the 
intensity of fluorescence along the entire cell. Details of these analyses are provided in 
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Chapter 4. As living cells were being treated, multiple stack-derived images of the same 
cell were compared for each treatment. Many characteristics were available for regions of 
interest (ROI) within each cellular image; however, the maximum fluorescence intensity 
was chosen because it is associated with clustering of the receptor since an increase in 
this value would indicate the coalescence of fluorescence puncta or clustering. An 
increase in maximum intensity of a ROI would be interpreted as receptor clustering as 
this would result in more fluorescence tags grouped together to form a cluster of D1DRs. 
Fluorescence in infected explants was stable or would decrease slightly as some 
fluorescence bleaching does occur for vehicle-treated explants. The maximum intensity 
of fluorescence does not change significantly in corresponding regions of the cell after 60 










Figure 3-6. Two-dimensional representation of a z-axis stack. The brightest pixels in 
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Figure 3-7. Different viewing angles from a three-dimensional image that was 
created from a z-axis stack. A) Results were the same as the two-dimensional image 





Orthogonal planes of the cell were also investigated since the stack is a three-dimensional 
representation of the cell. If the two-dimensional image made from the stack (as in Figure 
3-6) was defined as the xy- plane, orthogonal planes of xz and yz were also made where z 
corresponds to the objective depth. The xz-plane corresponds to a plane protruding out of 
the xy-plane in a horizontal manner; while the yz-plane corresponds to a plane protruding 
out of the xy-plane in a vertical manner (see Figure 3-8). Orthogonal planes were 
examined in multiple cells where increases in fluorescence were observed in order to 
demonstrate a more conclusive localization of clustering and to show the position of the 







Figure 3-8. Illustration of the three orthogonal planes that can be examined using 
Metamorph. These additional views help to determine the localization of clusters to 
determine position relative to the cell surface. 
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Chapter 4: Dopamine and Ethanol Induced Trafficking of eGFP-D1DR 
in Parasagittal Explants 
4-1. INTRODUCTION 
The mesolimbic pathway has been implicated in the rewarding actions of drugs of abuse 
(Wise, 1996; Koob et al., 1998). This dopaminergic pathway originates in the VTA and 
projects to the NAcc and other areas (Ungerstedt, 1971; Oades and Halliday, 1987; Van 
Bockstaele and Pickel, 1995; Feldman et al., 1997). The principle neurons of the NAcc 
are medium spiny neurons (Meredith, 1999). The major output of the NAcc is to the 
ventral pallidum (Swanson and Cwan, 1975); however, medium spiny neurons also 
project back to the VTA, creating feed-back circuitry (Walaas and Fonnum, 1980; 
Heimer et al., 1991). Drugs of abuse increased extracellular dopamine in the NAcc 
through a variety of mechanisms. For instance, ethanol directly stimulated the 
dopaminergic cells of the VTA (Brodie et al., 1999) and increased the neuronal firing rate 
which induced the synaptic release of dopamine into the NAcc. Since ethanol and other 
drugs of abuse may be associated with enhanced extracellular dopamine levels in the 
NAcc, the post-synaptic neuroadaptations resulting from elevated dopamine may be 
significant to understanding drug abuse and addiction. 
 
D1DRs mediate a substantial component of dopaminergic signaling in the NAcc (Boyson 
et al., 1986; Hersch et al., 1995; Caille et al., 1996). Like other receptors belonging to the 
GPCR family, these receptors undergo agonist-induced desensitization (Kallal and 
Benovic, 2000). D1DR desensitization may occur by multiple mechanisms, including 1) 
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uncoupling from the G-protein (Memo et al., 1982), 2) internalization of the receptor (Ng 
et al., 1995) and 3) down regulation of D1DR expression of the (Barton and Sibley, 
1990). D1DR internalization upon agonist stimulation has not been observed previously 
in viable mammalian cells.  
 
Not only can ethanol directly stimulate the dopaminergic cells of the VTA, it also alters 
cAMP-mediated cascades stimulated by dopamine and other receptors in a variety of cell 
types. Acute ethanol exposure increased cAMP production upon stimulation of receptors 
coupled to adenylyl cyclase (Hynie et al., 1980; Gordon et al., 1986). Since modulation 
of the cAMP cascade via cAMP analogs was associated with desensitization of the D1DR 
(Black et al., 1994), it is feasible that ethanol (acting on cAMP) could also induce D1DR 
desensitization. The hypothesis of this dissertation project is that ethanol will induce 
internalization of D1DRs; however, the distinction between pre- (dopamine release in the 
NAcc) and post-synaptic actions (cAMP modulation) of ethanol can not be concluded. 
 
If dopamine and ethanol can individually induce D1DR clustering and internalization, 
then a pretreatment of ethanol, thereby priming cAMP cascades, may increase the 
internalization induced by dopamine alone. Dopamine and ethanol modulation of the 
localization and thereby function of the D1DR could contribute, at least in part, to the 
neuroadaptive changes associated with addiction in the mesolimbic system. In order to 
test this hypothesis, parasagittal brain slice explants were studied that include viable 
medium spiny neurons of the NAcc that retain many synaptic connections observed in 
vivo. Explants were infected with a sindbis pseudovirus modified to express eGFP-
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D1DR. Thus, labeled D1DRs were localized in real-time using MPLSM. Our results 
indicate that high levels of dopamine receptor activation caused eGFP-D1DRs to cluster 
away from the cell surface, consistent with desensitization in the form of receptor 
internalization. However, a lower level of dopamine that did not induce receptor 
clustering alone, when pretreated with ethanol, appeared to act in concert with ethanol to 
cause clustering. Ethanol alone also produced receptor clustering. The clustering was 
inhibited by the D1DR antagonist SCH 23390. 
4-2. METHODS 
4-2.1. Explant Preparation  
Parasagittal explants were prepared from Sprague Dawley rat pups as described 
previously (see section 3-3.2 Explant Methods). 
4-2.2. Infection of Explant 
The subcloning of eGFP-D1DR into the sindbis pseudovirus was described in chapter 2 
and has also been published by our lab (Diaz et al., 2004). Explants were infected at 2-6 
locations on each slice using 50-100 nL of virus per injection. Cells were imaged 
approximately 48 hours after infection. 
4-2.3. Multi-photon Laser Scanning Microscopy 
eGFP fluorescence was induced by two-photon excitation at 845 nm using a mode-locked 
Spectra-Physics (A division of Newport Corp, Irvine , CA) Tsunami titanium:sapphire 
laser pumped by a Millenia 5W argon source (as described previously in section 3-4.). 
 86
Acquisition of fluorescence data was controlled by a modified Olympus (Melville, NY) 
Fluoview scanhead mounted on an Olympus BX-50W1 microscope (40x WI objectives 
and 1-5 x digital zoom). Fluoview-controlled stacks were collected along the z-axis, with 
z-steps of 0.5-0.7 um for three-dimensional imaging of individual neurons in explants. 
Laser power was approximately 100 mW measured at the Tsunami and was confirmed 
before the acquisition of each stack in order to verify laser stability and constant 
excitation levels. The photomultiplier tube detector settings were kept constant for each 
cell at each time point. Therefore, differences in fluorescence were presumed to be 
indicative of biological changes and not of changes in excitation or detection. Offline 
quantification and image analysis were completed using Metamorph imaging software 
(Universal Imaging Corporation, Downingtown, PA). 
4-2.4. Explant Treatments 
Explant membrane inserts were securely attached to a removable custom-made chamber 
that was attached to the microscope stage. The chamber consisted of a base secured to the 
microscope stage with two small clamps that fastened the insert to the chamber base by 
thumbscrews. An opening was centered in the base of the chamber and a glass slide was 
glued for a transparent field of view. The perfusion buffer was Hank’s Balanced Salt 
Solution (HBSS, Invitrogen, Carlsbad, CA) containing in (mM): CaCl2 (1.3), MgCl2-
6H2O (0.5), MgSO4-7H2O (0.4), KCl (5.3), KH2PO4 (0.4), NaCl (138), Na2HPO4-7H2O 
(0.3), Dextrose (5.5), with added HEPES (11), NaHCO3 (25), and L-Ascorbic Acid (0.2). 
HBSS was gassed continuously with 95% O2/ 5% CO2) and perfused continuously across 
the chamber at 1.5 mL/min. HBSS was perfused through an in-line heater (32-35 °C) 
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located between the HBSS reservoir and the custom made chamber. The bath level was 
maintained by suction from a glass capillary (2mm) connected to a waste reservoir. 
 
All explants were treated with HBSS for a baseline image collected at time zero minutes. 
A control group was exposed to HBSS for all time points: 0, 30 and 60 minutes. After 
baseline imaging, treatment groups were exposed to drug solutions in 30 minute intervals. 
Experiments were designed to test clustering and/or internalization induced by dopamine, 
ethanol pretreatment of dopamine, or ethanol treatment alone. Specific treatments are 





Table 4-1. Treatment groups for control and dopamine experiments 
Group Condition at 
t = 0 min 
Condition at 
t = 30 min 
Condition at 
t = 60 min 
Control HBSS HBSS HBSS 
Dopamine 
(50 uM) 
HBSS HBSS Dopamine (50 uM) 
Dopamine 
(100 uM) 
HBSS HBSS Dopamine (100 uM) 
SCH 23390 
(20 uM) 
HBSS SCH 23390 (20 uM) SCH 23390 (20 uM) + 
Dopamine (100 uM) 
Table 4-2. Treatment groups for ethanol pretreatment experiments 
Group Condition at 
t = 0 min 
Condition at 
t = 30 min 
Condition at 
t = 60 min 
Dopamine  
(50 uM) 
HBSS HBSS Dopamine (50 uM) 
Ethanol (50 mM) /  
Dopamine (50 uM) 
HBSS Ethanol (50 mM) Dopamine (50 uM) 
Ethanol (100 mM) / 
Dopamine (50 uM) 
HBSS Ethanol (100 mM) Dopamine (50 uM) 
Pretreatment +  
SCH 23390 (20 uM) 
HBSS SCH 23390 (20 uM) 
+ Ethanol (100 mM) 
SCH 23390 (20 uM )+ 
Dopamine (50 uM) 
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Table 4-3. Treatment groups for ethanol experiments 
Group Condition at 
t = 0 min 
Condition at 
t = 30 min 
Condition at  
t = 60 min 
Control HBSS HBSS HBSS 
Ethanol (50 mM) HBSS Ethanol (50 mM) Ethanol (50 mM) 
Ethanol (100 mM) HBSS Ethanol (100 mM) Ethanol (100 mM) 
Ethanol + SCH 
23390 (20 uM) 
HBSS SCH 23390 (20 uM )+ 
Ethanol (100 mM) 
SCH 23390 (20 uM )+  
Ethanol (100 mM) 
 
4-3. IMAGE ANALYSIS 
Each stack of images was converted into a two-dimensional projection image using the 
Metamorph stack arithmetic command with the maximum factor chosen. This command 
acquires the maximum intensity for each pixel position throughout the entire stack, 
resulting in one image that represents the maximum intensity of the entire cell. This was 
done for each cell at time points 0, 30 and 60 minutes.  
 
ROI were determined in a multi-step process. Typically, about 50-70 z-steps (0.5-0.7 um 
per step) were completed for a cross-section z-distance of about 25-50 um. The cells were 
not completely stable in position due to physical and thermal drift inherent in real-time 
imaging of a perfused preparation; this made direct image comparisons difficult since the 
required degree of overlay of cell processes was highly unlikely. Therefore, smaller more 
stable areas of each cell were aligned using Metamorph software at the baseline and final 
images. After alignment, an image subtraction was performed and this subtraction image 
then underwent thresholding. Thresholding enables the software to automatically detect 
ROIs which correspond to changes between the final and baseline images. These ROIs 
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were reassigned as circles with an approximate diameter of 15 pixels for uniformity. 
ROIs were then transferred from the subtraction image to the original stack-generated 
two-dimensional images for each sampled time point. Individual ROIs were realigned 
and analyzed using Metamorph to measure the maximum fluorescence intensity for each 
ROI at each time point. While many characteristics were available to quantitate ROIs, the 
maximum fluorescence intensity was chosen because it is associated with receptor 
clustering. Two primary measures were provided by this analysis: 1) the greatest increase 
in maximum fluorescence intensity of a ROI for each cell and 2) the number of ROIs that 
increased more than 20% from baseline. These two measures provided different aspects 
of receptor clustering within the cell. The number of ROIs that increased more than 20% 
from baseline provides an overall view of clustering by the cell while the peak increase in 
fluorescence intensity reflects the brightest cluster. Therefore, this detection protocol was 
comprehensive and unbiased as the software was utilized to autodetect ROIs 
representative of changes in receptor localization or clustering.  
 
Changes in fluorescence localization were inspected further by constructing images of 
orthogonal planes. Using Metamorph software, multiple areas associated with increased 
maximum intensity in the xy-plane were inspected in both the xz- and yz-planes by 
reanalysis of the stacks at these positions. These orthogonal planes gave further 
information on the three dimensional position of fluorescence intensity associated with 
receptor clustering. It is presumed that the orthogonal planes indicate if the clustering 
appears on the cell surface or within the cell; such changes not only indicate alterations in 
receptor localization but function as well. 
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4-3.1. Statistical Analysis 
Two-way ANOVAs (treatment, time) with repeated measures followed by Bonferroni 
correction were completed on raw greatest increase in maximum intensity data. Post-hoc 
analysis by Student’s T-test with Bonferroni correction of 8 (4 treatments, 2 time points) 
comparisons of interest was performed. Two-way ANOVAs (treatment, time) with 
repeated measures and Bonferroni correction were also completed on data normalized to 
the baseline image. Non-parametric Kruskal-Wallis statistical analysis with Dunn’s 
multiple comparison test were used on frequency of increases in maximum fluorescence 
intensity of 20% or more at the 60 minute time point compared to baseline. 
4-4. RESULTS 
Due to the visual nature of these studies, images have been provided for qualitative 
analysis, followed by tables of raw data and graphs that provide quantitative measures for 
the effects of dopamine alone, ethanol priming dopamine and ethanol alone.  
4-4.1. Control and Dopamine Experiments 
First, the stability of eGFP-D1DR fluorescence was assessed over extended scanning 
periods. As described above in the methods section, the ROI assignment protocol was 
used to identify ROIs where eGFP-D1DR puncta were observed. Control cells, as shown 
in Figure 4-1, displayed no significant increase in maximum fluorescence intensity. Cells 
that were exposed to 50 uM dopamine also showed no significant increase in maximum 
fluorescence intensity in any ROI (Figure 4-2). Fluorescence stability was evident since 
there were not any ROIs that increased in maximum fluorescence intensity of 20% or 
more (Figure 4-8). When cells were treated with higher concentrations of dopamine (100 
uM), an increase in maximum fluorescence intensity was seen in discrete ROIs (Figure 4-
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3). This clustering of fluorescence (and hence receptors) appeared to be centered inside of 
the cell process as illustrated using orthogonal planes. Interestingly, Figure 4-4 is a 
second example of dopamine (100 uM) treatment that exemplifies clustering of the 
receptor toward the cell surface as revealed by viewing the orthogonal planes. Clustering 
was partially blocked by the D1DR antagonist, SCH 23390 (20 uM) as seen in Figure 4-
5. 
 
We wanted to further verify that puncta identified by the automated ROI protocol were 
indeed discrete ROIs exhibiting consistent changes in eGFP-D1DR fluorescence. Thus, 
random ROIs were also measured by obtaining coordinates assigned using the random 
number generator in Microsoft Excel (2002 version 10.2614.2625 Microsoft, Redmond, 
WA). The dimensions of each image were 640 x 480 pixels; therefore, excel commands 
[RANDBETWEEN(0, 640), and RANDBETWEEN(0, 480)] were used to obtain random 
coordinates for ROIs. Random measurements illustrated that fluorescence intensity was 
stable despite treatment with SCH 23390 or 100 uM dopamine (Figure 4-6). Therefore, in 
this study clustering of receptors appears to occur only in discrete ROIs in cells that have 







Figure 4-1. Example of a typical control neuron, treated with only HBSS buffer. A) 
A two-dimensional image of eGFP-D1DR fluorescence of a typical medium spiny neuron 
in the NAcc of a parasagittal explant (xy-plane). The white box indicates areas of 
magnification for additional planes. B) The xy-plane magnified in the area marked by the 
white box at 0, 30 and 60 minutes. C) The yz-plane magnified in the same area at 0, 30 












Figure 4-2. Example of a typical neuron exposed to dopamine (50 uM) for 30 
minutes. A) A two-dimensional image of eGFP-D1DR fluorescence of a typical medium 
spiny neuron in the NAcc of a parasagittal explant (xy-plane). The white box indicates 
areas of magnification for additional planes. B) The xy-plane magnified in the area of the 
white box at 0, 30 and 60 minutes. C) The yz-plane magnified n the same area at 0, 30 








Figure 4-3. Example of a typical neuron exposed to dopamine (100 uM) for 30 
minutes. A) A two-dimensional image of eGFP-D1DR fluorescence of a typical medium 
spiny neuron in the NAcc of a parasagittal explant (xy-plane). The white box indicates 
areas of magnification for additional planes. B) The xy-plane magnified in the area of the 
white box at 0, 30 and 60 minutes. C) The yz-plane magnified in the same area at 0, 30 
and 60 minutes. D) The xz-plane magnified in the same area at 0, 30 and 60 minutes. The 









Figure 4-4. Example of a typical neuron exposed to dopamine (100 uM) for 30 
minutes. A) A two-dimensional image of eGFP-D1DR fluorescence of a typical medium 
spiny neuron in the NAcc of a parasagittal explant (xy-plane). The white box indicates 
areas of magnification for additional planes. B) The xy-plane magnified in the area of the 
white box at 0, 30 and 60 minutes. C) The yz-plane magnified in the same area at 0, 30 
and 60 minutes. D) The xz-plane magnified in the same area at 0, 30 and 60 minutes. The 










Figure 4-5. Example of a typical neuron exposed to SCH 23390 (20 uM) plus 
dopamine (100 uM) for 30 minutes. Treatment consisted of 20 uM SCH 23390 for 30 
minutes followed by 20 uM SCH 23390 +100 uM dopamine for 30 minutes. A) A two-
dimensional image of eGFP-D1DR fluorescence of a typical medium spiny neuron in the 
NAcc of a parasagittal explant (xy-plane). The white box indicates areas of magnification 
for additional planes. B) The xy-plane magnified in the area of the white box at 0, 30 and 
60 minutes. C) The yz-plane magnified in the same area at 0, 30 and 60 minutes. D) The 



























































  Random HBSS
  Random DA(100)
  Random DA(50)
  Random SCH + DA(100)
 
Figure 4-6. Randomly assigned regions of interest as a percent of baseline (0 time 
point) for dopamine experiments. Random coordinates were generated to determine 
that cells were generally stable. Cells displayed only a slight, non significant bleaching 







The raw data for the greatest increases in maximum fluorescence intensity (Table 4-4) 
were analyzed by two-way ANOVA (treatment, time); time was significantly different (F 
(2, 32) = 9.86 P ≤ 0.0005) but treatment (F (3, 32) = 1.56, P = 0.238) and the interaction 
were not significantly different (F (6, 32) = 2.26, P = 0.063). Additionally, the baseline 
image and SCH 23390 (20 uM, 30 minutes) are not significantly different (P = 0.658), 
implying that SCH 23390 has no effect alone on D1DR clustering. 
 
Table 4-4. Raw data for greatest increase in maximum fluorescence intensity at the 
60 minute time point compared to baseline (0 minute time point) for dopamine 
experiments. Maximum fluorescence intensities are given in arbitrary units on a 12 bit 
scale (0 to 4095). 
Treatment Avg Max 
Intensity  
(0 min) 
SEM Avg Max 
Intensity 
(30 min) 




HBSS / HBSS / HBSS 2409 139 2262 267 2500 141
HBSS / HBSS / DA (50 uM) 2970 279 2853 191 3045 263
HBSS / HBSS / DA (100 uM) 2082 118 2258 154 2936 61
HBSS / SCH 23390 (20 uM) / 
SCH 23390 + DA (100 uM) 
2238 353 2320 335 2565 396
 
Figure 4-7 illustrates the greatest increase in maximum fluorescence intensity as a percent 
of baseline (0 minute time point) for the 30 and 60 minute time points. A two-way 
ANOVA (treatment, time) analysis on the values (expressed as percent of baseline) 
revealed significant treatment (F (3, 6) = 3.50, P ≤ 0.05) and time (F (1, 16) = 11.92, P ≤ 
0.005) effects but no significant interaction (F (3, 16) = 2.37, P = 0.109). A post-hoc 
evaluation by Student’s T-test with 8 comparisons of interest (4 treatments, 2 time points) 
showed a significant difference for the 60 minute time point between control and 
dopamine (100 uM) treatment (P ≤ 0.05) as well as a significant difference between 




















































 HBSS / HBSS / HBSS
 HBSS / HBSS / DA (50)
 HBSS / HBSS / DA (100)
 HBSS / SCH (20) / SCH (20) + DA (100)
*
 
Figure 4-7. Control and dopamine experiment greatest increases in maximum 
fluorescence intensity at the 60 minute time point compared to baseline (0 minute 
time point). Control and dopamine- (100 uM) treated cells were significantly different at 
the 60 minute time point. SCH 23390 (20 uM) treatment significantly inhibited the effect 
of dopamine (100 uM). Error bars are ± SEM. Asterisks indicate results of statistical tests 





No increases in maximum fluorescence intensity above 20% were observed at the 60 
minute time point in control cells or cells exposed to 50 uM dopamine, thereby indicating 
that clustering of D1DRs was not detectable under these conditions. However, a higher 
concentration of dopamine (100 uM) produced D1DR clustering as seen by an increase in 
maximum intensity above 20% at the 60 minute time point compared to the baseline 
image (Figure 4-8). Kruskal-Wallis nonparametric statistics with Dunn’s multiple 
comparison test showed a significant difference between dopamine (100 uM) treatment 
and control or dopamine (50 uM) treatment (P ≤ 0.01) as well as between dopamine (100 










































HBSS / HBSS / HBSS
HBSS / HBSS /  DA (50)
HBSS / HBSS /  DA (100)
HBSS / SH (20)  / SCH(20) + DA (100)
 
Figure 4-8. Control and dopamine experiment frequency of increases in maximum 
fluorescence intensity above 20% at the 60 minute time point compared to baseline 
(0 minute time point). There were significant differences between 100 uM dopamine 
and control or 50 uM dopamine; there was also a significant inhibition of 100 uM 
dopamine by 20 uM SCH 23390. Error bars are ± SEM. Asterisks indicate results of 





4-4.2. Ethanol Pretreatment Experiments 
Cells exposed to dopamine (50 uM) displayed no detectable increases in eGFP-D1DR 
maximum fluorescence intensity as shown in Figure 4-9. However, if cells were 
pretreated with ethanol (50 or 100 mM) and then exposed to dopamine (50uM), 
clustering was observed. Figure 4-10 shows an example of 50 mM ethanol preceding 50 
uM dopamine treatment, and clustering is indicated by white outlines in Figure 4-10B, C 
and D. Clustering was also observed with 100 mM ethanol pretreatment of 50 uM 
dopamine as seen in Figure 4-11. This effect was inhibited by the D1DR antagonist SCH 





Figure 4-9. Example of a typical neuron treated with dopamine (50 uM) for 30 
minutes. A) A two-dimensional image of eGFP-D1DR fluorescence of a typical medium 
spiny neuron in the NAcc of a parasagittal explant (xy-plane). The white box indicates 
areas of magnification for additional planes. B) The xy-plane magnified in the area of the 
white box at 0, 30 and 60 minute time points. C) The yz-plane magnified in the same area 










Figure 4-10. Example of a typical neuron exposed to ethanol (50 mM) for 30 minutes 
followed by dopamine (50 uM) for 30 minutes. A) A two-dimensional image of eGFP-
D1DR fluorescence of a typical medium spiny neuron in the NAcc of a parasagittal 
explant (xy-plane). The white box indicates areas of magnification for additional planes. 
B) The xy-plane magnified in the area of the white box at 0, 30 and 60 minutes. C) The 
yz-plane magnified in the same area at 0, 30 and 60 minutes. D) The xz-plane magnified 









Figure 4-11. Example of a typical neuron exposed to ethanol (100 mM) for 30 
minutes followed by dopamine (50 uM) for 30 minutes. A) A two-dimensional image 
of eGFP-D1DR fluorescence of a typical medium spiny neuron in the NAcc of a 
parasagittal explant (xy-plane). The white box indicates areas of magnification for 
additional planes. B) The xy-plane magnified in the area of the white box at 0, 30 and 60 
minutes. C) The yz-plane magnified in the same area at 0, 30 and 60 minutes. D) The xz-
plane magnified in the same area at 0, 30 and 60 minutes. The white circles show 









Figure 4-12. Example of a typical neuron exposed to SCH 23390 (20 uM) plus 
ethanol (100 mM) for 30 minutes followed by SCH 23390 plus dopamine (50 uM) for 
30 minutes. A) A two-dimensional image of eGFP-D1DR fluorescence of a typical 
medium spiny neuron in the NAcc of a parasagittal explant (xy-plane). The white box 
indicates areas of magnification for additional planes. B) The xy-plane magnified in the 
area of the white box at 0, 30 and 60 minutes. C) The yz-plane magnified in the same 





These images were quantified using Metamorph software as described previously; both 
raw data (Table 4-5) and data expressed as percent of baseline for the greatest increases 
in maximum intensity at the 60 minute time point have been provided. A two-way 
ANOVA (treatment, time) performed on the raw values showed a significant effect of 
treatment (F (3, 32) = 4.20, P ≤ 0.05), time (F (2, 32) = 33.47, P ≤ 0.0001), and the 
interaction (F (6, 32) = 6.28, P ≤ 0.0005) of ethanol pretreatment of dopamine (50 uM). 
 
Table 4-5. Raw data for greatest increase in maximum fluorescence intensity at the 
60 minute time point as compared to baseline for ethanol pretreatment experiments. 
Maximum fluorescence intensities are given in arbitrary units on a 12 bit scale (0 to 
4095). 
Treatment Avg Max 
Intensity 
(0 min) 
SEM Avg Max 
Intensity 
(30 min) 




HBSS / HBSS / DA (50 uM) 2970 278 2853 191 3045 263.
HBSS / EtOH (50 mM) / 
DA (50 uM) 
2294 76 3015 128 3438 95
HBSS / EtOH (100 mM) / 
DA (50 uM) 
1316 106 2303 319 2748 242 
HBSS / SCH 23390 (20 uM) + 
EtOH (100 mM) / SCH 23390 
(20 uM) + DA (50 uM) 




Figure 4-13 depicts the effect of ethanol pretreatment on the greatest increase in 
maximum fluorescence intensity of a ROI in each cell at 30 and 60 minutes. A two-way 
ANOVA (treatment, time) performed on the values expressed as percent of baseline 
showed a significant treatment (F (3, 16) = 18.29, P ≤ 0.0001) but no time (F (1, 16) = 
3.52, P = 0.079) or interaction (F (3, 16) = 0.43, P = 0.7377) effect. A post-hoc 
evaluation by Student’s T-test with a Bonferroni correction for 8 (4 treatments, 2 time 
points) comparisons of interest revealed a significant difference at the 60 minute time 
point between dopamine (50 uM) and dopamine (50 uM) pretreated with ethanol (50 
mM, P ≤ 0.00005 and 100 mM, P ≤ 0.00005). A significant difference was also observed 
between SCH 23390, applied during the ethanol (100 mM) pretreatment and during the 
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subsequent dopamine (50 uM) application, compared to ethanol (100 mM) pre-exposure 












































 HBSS / HBSS / DA (50)
 HBSS / EtOH (50) / DA (50)
 HBSS / EtOH (100) / DA (50)
 HBSS / SCH (20) + EtOH (100) / SCH (20) + DA (50)
*
 
Figure 4-13. Ethanol pretreatment experiment greatest increases in maximum 
fluorescence intensity at the 60 minute time point compared to baseline (0 minute 
time point). There was a significant difference between dopamine- (50 uM) exposed 
cells and those that were pretreated with ethanol (50 or 100 mM) at the 60 minute time 
point. SCH 23390 (20 uM) significantly inhibited the effect of ethanol (100 mM) 
pretreatment of dopamine (50 uM). Error bars are ± SEM. Asterisks indicate results of 





Figure 4-14 represents frequency of increases (above 20%) in maximum fluorescence 
intensity at 60 minutes compared to baseline for each treatment. No such increases were 
observed in cells treated with dopamine (50 uM), indicating that D1DRs did not undergo 
detectable clustering under this condition. However, when this concentration of dopamine 
was pretreated with ethanol (50 mM or 100 mM), clustering did occur as indicated by 
increases in maximum intensity above 20%. Kruskal-Wallis non-parametric statistical 
comparisons with Dunn’s multiple comparison tests revealed significant differences 
between cells treated with dopamine (50 uM) alone and cells pretreated with ethanol (50 
or 100 mM) followed by dopamine (50 uM) (P ≤ 0.05, P ≤ 0.01 respectively). The 
frequency was also significantly different between ethanol (100 mM) pretreatment of 



















































HBSS / HBSS / DA (50)
HBSS/ EtOH (50) / DA (50)
 HBSS/ EtOH (100) / DA (50)
 HBSS / SCH (20) +EtOH (100) / SCH (20) +DA (50)
*
 
Figure 4-14. Ethanol pretreatment experiment frequency of increase in maximum 
fluorescence intensity above 20% at the 60 minute time point as percent of baseline 
(0 minute time point). There were significant differences between dopamine (50 uM) 
and ethanol (50 or 100 mM) pretreatment of dopamine and a significant inhibition when 
SCH 23390 (20 uM) was present with ethanol (100). Error bars are ± SEM. Asterisks 






4-4.3. Ethanol Experiments 
Ethanol treatment alone (in the absence of dopamine) was also investigated. Figure 4-15 
is another example of a control cell, and again there is no significant increase in 
fluorescence intensity apparent across time. Figure 4-16 shows a cell that was exposed to 
ethanol (50mM) for 1 hour after the baseline image. Specific ROIs indicative of 
fluorescence puncta were enhanced. Figure 4-17 is an example of a cell exposed to 
ethanol (100mM) for one hour after the baseline image was acquired; again, increases in 
ROIs indicating enhancement of fluorescence intensity, were noted at 30 and 60 minutes. 
Very distinct translocation of cell surface fluorescence was reproducibly indicated by 
orthogonal images, showing initial absence of intracellular fluorescence in baseline 
images that were increased after ethanol exposure (Figures 4-16 C and D and 17 C and 
D). Figure 4-18 shows a cell that was exposed to SCH 23390 (20 uM) plus ethanol 
(100mM) for 1 hour; no significant increases in fluorescence intensity were observed at 





Figure 4-15. Example of a typical control neuron treated only with HBSS. A) A two-
dimensional image of eGFP-D1DR fluorescence of a typical medium spiny neuron in the 
NAcc of a parasagittal explant (xy-plane). The white box indicates areas of magnification 
for additional planes. B) The xy-plane magnified in the area of the white box at 0, 30 and 
60 minutes. C) The yz-plane magnified in the same area at 0, 30 and 60 minutes. D) The 









Figure 4-16. Example of a typical neuron exposed to ethanol (50 mM) for 60 
minutes. A) A two-dimensional image of eGFP-D1DR fluorescence of a typical medium 
spiny neuron in the NAcc of a parasagittal explant (xy-plane). The white box indicates 
areas of magnification for additional planes. B) The xy-plane magnified in the area of the 
white box at 0, 30 and 60 minutes. C) The yz-plane magnified in the same area at 0, 30 
and 60 minutes. D) The xz-plane magnified in the same area at 0, 30 and 60 minutes. The 
white circles show increases in fluorescence intensity. White arrows indicate the lack of 









Figure 4-17. Example of a typical neuron exposed to ethanol (100 mM) for 60 
minutes. A) A two-dimensional image of eGFP-D1DR fluorescence of a typical medium 
spiny neuron in the NAcc of a parasagittal explant (xy-plane). The white box indicates 
areas of magnification for additional planes. B) The xy-plane magnified in the area of the 
white box at 0, 30 and 60 minutes. C) The yz-plane magnified in the same area at 0, 30 
and 60 minutes. D) The xz-plane magnified in the same area at 0, 30 and 60 minutes. The 
white circles show increases in fluorescence intensity. White arrows indicate the lack of 






Figure 4-18. Example of a typical neuron exposed to SCH 23390 (20 uM) plus 
ethanol (100 mM) for 60 minutes. A) A two-dimensional image of eGFP-D1DR 
fluorescence of a typical medium spiny neuron in the NAcc in a parasagittal explant (xy-
plane). The white box indicates areas of magnification for additional planes. B) The xy-
plane magnified in the area of the white box at 0, 30 and 60 minutes. C) The yz-plane 
magnified in the same area at 0, 30 and 60 minutes. D) The xz-plane magnified in the 





These images were quantified using Metamorph software as described previously; both 
raw data and data expressed as percent increases in maximum fluorescence intensity at 
the 60 minute time point (when compared to baseline) are provided. A two-way ANOVA 
(treatment, time) performed on the raw values of maximum intensity (Table 4-6) showed 
a significant time (F (2, 32) = 24.86, P ≤ 0.0001) and interaction (F (6, 32) = 3.84, P ≤ 
0.01) but no treatment (F (3, 32) = 0.63, P = 0.6057) effect by ethanol alone. 
 
Table 4-6. Raw data for greatest increase in maximum fluorescence intensity at the 
60 minute time point as compared to baseline (0 minute time point) for ethanol 
experiments. Maximum fluorescence intensities are given in arbitrary units on a 12 bit 
scale (0 to 4095). 
Treatment Avg Max 
Intensity 
(0 min) 
SEM Avg Max 
Intensity 
(30 min) 




HBSS / HBSS / HBSS 2409 138 2262 266 2500 140
HBSS / EtOH (50 mM) / 
EtOH 
1484 153 2041 204 2418 
 
236
HBSS / EtOH (100 mM) / 
EtOH  
1678 245 2076 322 2646 
 
312 
HBSS / SCH 23390 (20 uM) + 
EtOH (100 mM) / SCH 23390 
+ EtOH 




The normalization of these data is represented in Figure 4-19. This depicts the greatest 
increase as a percent of baseline in a ROI for each cell in each treatment at 30 and 60 
minutes. A two-way ANOVA (treatment, time) performed on the percent values showed 
a significant treatment (F (3, 16) = 12.09, P ≤ 0.0005), time (F (1, 16) = 11.69, P ≤ 
0.005), but not interaction (F (3, 16) = 2.25, P = 0.1216) effect. A post-hoc evaluation by 
Student’s T-test with 8 comparisons of interest (4 treatments, 2 time points) revealed a 
significant difference at the 60 minute time point between control cells and those exposed 
to 50 mM ethanol (P ≤ 0.00001) or 100 mM ethanol (P ≤ 0.001). A significant difference 
was also observed between SCH 23390 plus ethanol (100 mM) compared to ethanol (100 














































 HBSS / HBSS / HBSS
 HBSS / EtOH (50) / EtOH (50)
 HBSS / EtOH (100) / EtOH (100)
 HBSS / SCH (20)+EtOH (100) / SCH (20)+EtOH (100)
*
 
Figure 4-19. Ethanol experiment greatest increases of maximum fluorescence 
intensity at the 60 minute time point compared to baseline (0 minute time point). 
The greatest increase in maximum fluorescence intensity for a ROI was determined. 
Control cells and cells exposed to ethanol (50 mM as well as 100 mM) were significantly 
different at the 60 minute time point; SCH 23390 (20 uM) treatment significantly 
inhibited the effect of ethanol (100 mM). Error bars are ± SEM. Asterisks indicate results 






Figure 4-20 represents frequency of increases above 20% in the maximum fluorescence 
intensity at 60 minutes compared to baseline. No such increases were observed in control 
cells, indicating the lack of D1DR clustering. However, when ethanol (50 mM or 100 
mM) was added to the perfusion buffer, distinct clustering and internalization occurred as 
indicated by strong increases in maximum intensity. Kruskal-Wallis non-parametric 
statistical analysis with Dunn’s multiple comparison tests showed a significant difference 
between the frequency of increases above 20% in control cells and cells that were 
exposed to ethanol (50 mM or 100 mM) for one hour (P ≤ 0.01, P ≤ 0.05 respectively). A 
significant difference was also observed between ethanol (50 mM) and SCH 23390 plus 


















































 HBSS / HBSS / HBSS
 HBSS / EtOH (50) / EtOH (50)
 HBSS / EtOH (100) / EtOH (100)
 HBSS / SCH (20) + EtOH (100) / SCH (20) + EtOH (100)
*
 
Figure 4-20. Ethanol experiment frequency of increases in maximum fluorescence 
intensity above 20% at the 60 minute time point as percent of baseline (0 minute 
time point). There was a significant difference between control and ethanol- (50 or 
100mM) exposed cells and a significant difference between ethanol- (50mM) treatment 
and SCH 23390 (20 uM) plus ethanol (100 mM). Error bars are ± SEM. Asterisks 







Receptor clustering of expressed D1DRs was observed in parasagittal explants imaged by 
two-photon laser scanning microscopy. The principle outcomes of this study included the 
following: (1) An automated procedure was developed to locate coalescence of 
fluorescent puncta that was both comprehensive and unbiased. (2) Orthogonal views of 
fluorescent puncta indicative of receptor clustering revealed that a majority of cell 
clustering was due to internalization of the receptor compared to only a few examples of 
cell-surface clustering. (3) Dopamine (100 uM) and ethanol (50 or 100 mM) 
causedD1DRs to cluster and internalize. (4) A lower concentration of dopamine (50 uM) 
produced no detectable internalization of the receptor; however, when the same 
concentration of dopamine was pretreated with ethanol (50 or 100 mM), internalization 
was observed. (5) Internalization of the receptor was inhibited by the D1DR antagonist 
SCH 23390 (20 uM). These are the first studies to show dopamine- or ethanol-induced 
D1DR internalization in real-time in viable mammalian neurons.  
 
Native D1DRs are widely expressed throughout the central nervous system. For example, 
D1DRs are expressed in the NAcc, frontal cortex, caudate-putamen, olfactory tubercle, 
entopeduncular nucleus (the rodent homolog of a portion of the globus pallidus), 
hippocampus, and the substantia nigra (Boyson et al., 1986; Altar and Marien, 1987; 
Ariano et al., 1991; Lidow et al., 1991; Mansour et al., 1992; Vincent et al., 1993). This 
extensive expression may be one reason why dopamine dysfunction has been associated 
with many disorders including Parkinson’s disease, Huntington’s disease, schizophrenia, 
hypertension, Tourette’s syndrome and addiction to drugs of abuse.  
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The subcellular localization of D1DRs is region specific; synaptic and extra-synaptic as 
well as post- and pre-synaptic localization have all been observed. In the striatum, 
D1DRs were highly expressed in the dendrites (especially the dendritic spines) and the 
cell body while axonal expression was observed less often (Levey et al., 1993; Hersch et 
al., 1995; Yung et al., 1995; Caille et al., 1996). Dendritic expression was occasionally 
postsynaptically opposed to afferent terminals. Double labeling of D1DRs and tyrosine 
hydroxylase (TH), the dopamine synthesis enzyme (Bagchi and McGeer, 1964), often 
showed D1DRs postsynaptic to TH, thereby demonstrating that striatal D1DRs may be 
extra-synaptic (Smiley et al., 1994; Caille et al., 1996). 
 
The eGFP tag on D1DRs allowed localization of the D1DR in neurons by MPLSM. This 
was accomplished by inserting the labeled D1DR into a sindbis virus expression system 
that produced functional D1DRs; this represented the first viral system for expressing 
eGFP-tagged D1DRs in mammalian cells (Diaz et al., 2004). The explants were infected 
with the sindbis psuedovirus in the NAcc which is composed of > 90% medium spiny 
neurons (Meredith, 1999) that endogenously express D1DRs (Altar and Marien, 1987; 
Ariano et al., 1991; Lidow et al., 1991; Mansour et al., 1992; Vincent et al., 1993; Wong 
et al., 1999) and is the primary target field of the dopaminergic cells from the VTA. 
However, it is possible that infected explants did not express eGFP-D1DR exclusively in 
the NAcc or did not have intact dopaminergic pathways. Physiological dopamine release 
is reported to begin at or before postnatal day 6 in the mouse ventromedial striatum, and 
striatal D1DRs are capable of transducing extracellular effects by postnatal day 4 in the 
mouse striatum (Kim et al., 2002a). This suggests that the development of dopamine 




Explants may also offer other advantages. Not only are there synaptic connections that 
may reflect in vivo pathways, but the viral expression of receptors in explants produced 
more physiological responses compared to dissociated neurons (Shi et al., 1999). In 
dissociated cells, viral-mediated expression of homomeric eGFP-tagged GluR1 receptors 
caused abnormal receptor transport to the synapse in the absence of conditioning 
stimulation; however, in explants conditioning stimuli were required for eGFP-tagged 
GluR1 receptor subunit insertion into the synapse. A difference in synaptic assembly 
between these two cellular models would be a critical factor, especially when studying 
receptor trafficking.  
 
Moreover, explants provide a more stable expression system with almost no evidence of 
viral-induced toxicity during the time-frame of these experiments. When using viral 
transfection to over-express proteins, compensatory changes and toxicity concerns must 
be considered. Although over expressing the D1DR may have long-term adverse effects, 
these cells were only infected for a short time; the infection period was approximately 
two days with expression occurring for less than two days. Many experiments were 
initially attempted in dissociated neuronal cultures that were more sensitive to infection, 
resulting in viral toxicity and cell death. However, very few cells in explants 
(approximately two in 200 scanned cells) showed toxicity. Explant cultures have been 
reported to tolerate sindbis pseudovirus infection quite well, depending on infection 
duration (Kim et al., 2004a). The sindbis pseudovirus, a suicide virus, theoretically 
infects only once since the structural proteins are not re-packaged in new virions; 
however, in practice approximately 15% of cells may be positive for structural proteins 
detected by antibodies raised against sindbis structural proteins (Kim et al., 2004a). 
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As seen in Figures 4-3 and 4-4, a high concentration of dopamine (100 uM) increased 
fluorescence intensity in discrete cell areas or puncta. Clustering may occur in particular 
areas that contain the necessary proteins for D1DR activation and trafficking. The 
differential location of receptor clustering is an interesting though not fully understood 
observation. For example, as shown in Figure 4-3 clustering occurred more centrally in 
the process while in Figure 4-4 clustering was more localized to the cell surface. Cell 
surface clustering has been reported following agonist stimulation for D1DRs on axons in 
fixed dissociated neurons whereas receptors on the cell body and dendrites clustered 
intracellularly (Martin-Negrier et al., 2000). Over-expression of D1DRs throughout the 
cell would be expected when using viral infection, so it is likely that axons also expressed 
D1DRs in our studies. Dissociated cell cultures displayed fluorescence throughout the 
cell (in all processes); therefore, explant expression was assumed to be similar. Cell 
surface clustering was observed in few cases possibly restricted to axons. In the NAcc 
axonal receptors would be extra-synaptic; extra-synaptic axonal D1DRs appear 
physiologically, although the purpose of these receptors is not well understood (Smiley et 
al., 1994; Caille et al., 1996). Dopamine transmission can be high volume, making these 
extra-synaptic receptors physiologically important under this condition. Native dendritic 
receptors would be activated by endogenous dopamine in the synapse, causing these 
receptors to internalize, in contrast with axonal receptors that would be exposed to less 
endogenous dopamine and may localize on the cell surface.  
 
The raw data for increases in the greatest maximum fluorescence intensity were 
dependent on many factors, thereby requiring data normalization compared to a baseline 
image. For example, the expression level of the eGFP-D1DR for each preparation was 
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variable, even though the same viral stock solution was used for most experiments. 
Another source of variability comes from the explants. On average, about six slices were 
prepared from one rat; therefore, the portion of NAcc present per explant differed. Laser 
alignment and other laser and detector characteristics could also vary from experiment to 
experiment. Because of the above factors, it was advantageous to image in real-time in 
viable cells from explants since this ensured that a baseline image could be made for 
direct within cell comparisons. However, the return of receptors to the cell surface could 
not be studied in our experiments. Previous reports have noted a seven hour requirement 
for D1DRs to return to the cell surface after internalization (Martin-Negrier et al., 2000). 
It is not feasible for explants to survive such a long time period on the microscope stage. 
 
The D1DR antagonist SCH 23390 inhibited receptor clustering in this study as well as in 
other studies reported in the literature. In several reports, D1DR desensitization was 
inhibited by SCH 23390 (Ofori et al., 1993; Lin et al., 1996; Dumartin et al., 1998; Lewis 
et al., 1998; Martin-Negrier et al., 2000; Gardner et al., 2001). In fact, repeated SCH 
23390 treatments caused an up-regulation of D1DR binding in several areas,including the 
rat striatum (Creese and Chen, 1985; Hess et al., 1986; Lappalainen et al., 1990; 
Schwartz et al., 2003). Since D1DR antagonists such as SCH 23390 bind without 
activating the receptor, this suggests that direct stimulation of the receptor is needed for 
desensitization.  
 
Amphetamine, a drug of abuse, that indirectly enhances catecholamine release from 
nerve terminals, also induces D1DR desensitization. A high dose of amphetamine (5.0 
mg/kg) produced a smaller increase in cAMP production compared to a lower dose (1 
mg/kg) (Barnett and Kuczenski, 1986; Roberts-Lewis et al., 1986). Chronic 
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administration of a moderate dose (3 mg/kg) of amphetamine also decreased cAMP 
production but had no effect on D1DR binding (Barnett et al., 1987), and a single 
maximal dose of 7.5 mg/kg amphetamine had similar results (Roseboom and Gnegy, 
1989). Internalization of D1DRs was observed upon amphetamine intraperitoneal 
injection, and this effect was inhibited when co-administered with the D1DR antagonist 
SCH 23390 (Dumartin et al., 1998). Therefore, other drugs of abuse that elevate 
extracellular dopamine levels also induce D1DR internalization. This underscores the 
importance of the D1DR in drug abuse and addiction. 
 
Other receptors have been reported to traffic to and from the plasma membrane of 
neurons. One example is the G-protein coupled mu-opioid receptor. Acute morphine 
administration caused internalization of mu-receptors, specifically in neuronal processes 
of the NAcc (Haberstock-Debic et al., 2003). This may be involved in opiate abuse and 
addiction. Also, GluR1 subunits of the AMPA receptor, a ligand-gated ion channel 
receptor, were redistributed to the cell surface upon conditioning stimulation (Shi et al., 
1999). AMPA receptor trafficking is believed to be part of the cellular mechanism of 
learning and memory and has also been implicated in the addiction process (Berke and 
Hyman, 2000). Additionally, D1DR stimulation increases surface expression of GluR1 
on neurons in the NAcc, further suggesting a role for D1DR in addiction (Chao et al., 
2002).  
 
The mechanism for ethanol-induced D1DR internalization is not fully understood; local 
effects of ethanol on cAMP cascades versus more systemic increases in dopamine release 
in the NAcc by activation of dopaminergic cells in the VTA were not differentiated. 
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Increased dopamine in the NAcc of explants by ethanol may not be sufficient to induce 
internalization, given that rather high levels of dopamine (100 uM) were required to 
induce clustering of the D1DR. Ethanol has been shown to have local effects on cAMP 
cascades (Hynie et al., 1980; Lucchi et al., 1983; Gordon et al., 1986; Tabakoff et al., 
2001; Maldve et al., 2002), and therefore ethanol action on such intracellular processes 
may be responsible for ethanol induction of D1DR trafficking. For example, alteration in 
the palmitoylation of the Gαs subunit of the G-protein upon ethanol exposure has been 
reported (Hallak and Rubin, 2004). This could modify expression, activity, or 
regulationof the Gαs subunit which in turn could affect adenylyl cyclase activity. Other 
ethanol effects may also play a role in the ethanol modulation of cAMP cascades, 
including the combination of a local increase in dopamine levels and alterations in the 
cAMP cascade.  
 
In conclusion, viral-mediated expression of eGFP-tagged D1DRs in parasagittal explants 
was used to study localization of D1DRs in viable mammalian neurons with MPLSM. An 
automated ROI protocol was developed to identify fluorescence punctate in ROIs which 
were sensitive to dopamine and/or ethanol application. Dopamine (100 uM) and ethanol 
(50 and 100 mM) exposure caused clustering of D1DRs away from the cell surface as 
seen by the three-dimensional images of cells transfected with eGFP-D1DR. This was the 
first study to demonstrate agonist-induced D1DR internalization in viable mammalian 
neurons. It was also the first study to provide evidence that ethanol induces D1DR 
internalization. 
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Chapter 5: Summary, Conclusions, and Future Directions 
5-1. SUMMARY AND CONCLUSIONS 
The sindbis pseudovirus was utilized to induce expression of eGFP-D1DRs in neurons of 
the NAcc in parasagittal brain slice culture (Diaz et al., 2004). Briefly, DNA for eGFP-
D1DR was inserted into the pSinRep5 vector, and RNA was transcribed in vitro from this 
vector and a helper vector encoding structural proteins. Electroporation was used to 
transfect BHK cells, and these cells then served as hosts to form pseudovirions that 
budded into the culture medium. Media was then collected and concentrated over a 
discontinuous sucrose gradient by ultra-centrifugation. The concentrated viral stock 
successfully infected dissociated neuronal cultures, brain slice explants, and mice in vivo. 
The ability of this virus to transfect different neuronal preparations demonstrates the 
utility of gene-transfer by viral infection.  
 
Evidence of functional receptors was shown by the ability of dopamine to stimulate 
cAMP in a concentration-dependent manner (Figure 3-2A). Moreover, the D1DR 
antagonist SCH 23390 inhibited dopamine-stimulated cAMP production in a 
concentration-dependent manner (Figure 3-2B). Thus, the virally-transfected D1DRs 
appeared to function similar to endogenous receptors since the expressed receptors bound 
agonist and activated synthesis of a second messenger via coupling to the G-protein, Gs 
and were also sensitive to the antagonist. Although an extensive concentration-response 
curve was not conducted, an estimated EC50 for the transfected eGFP-D1DR was 
approximately 11 uM dopamine which was similar to that reported for endogenous 
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D1DRs (for review see Neve and Neve, 1997). Cells expressing receptors showed a 
maximum cAMP production of 70 ± 0.7 pmol/mL, well within the range of the standard 
curve supplied by the cAMP detection kit (0.78-200 pmol/mL). In contrast, uninfected 
BHK cells displayed a maximum cAMP production of only 3 ± 0.6 pmol/mL, 
demonstrating that the cAMP response was dependent on the presence of functional 
D1DRs. The affinity estimate of the transfected D1DR (11 uM) was very similar to the 
low-affinity state of wildtype D1DRs that have a KD of 10-18 uM dopamine (for review 
see Neve and Neve, 1997). The EC50 for SCH 23390 in expressed D1DRs was 
approximately 1 nM which was similar to the wildtype D1DR affinity of 0.1-0.6 nM (for 
review see Neve and Neve, 1997). Therefore, there is ample evidence that the D1DRs 
expressed in explants were functionally similar to wildtype D1DRs. 
 
The parasagittal explants used in our studies were infected with the eGFP-D1DR sindbis 
pseudovirus in the NAcc, but the explants also contained the VTA, prefrontal cortex, and 
hippocampus. Since many brain regions associated with addiction to drugs of abuse were 
present in the explant, it may provide a physiological model for in vitro studies of drug-
induced neuroadaptive changes. TH staining further verified the presence of 
dopaminergic cells. 
 
MPLSM was used to localize eGFP-D1DRs in parasagittal explants. This imaging 
technique required characterization of the excitation and detection of eGFP in explants. 
Wavelength and power levels were determined for proper eGFP excitation through 
empirical tests, resulting in a laser wavelength of 845 nm and laser power of 
approximately 100 mW. Detection and power levels were kept constant for each 
experiment. Thus, only cellular differences in imaging were variable. 
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These experiments allowed monitoring of D1DR localization during the course of 
different pharmacological treatments. Images underwent a ROI protocol to search for 
increases in maximum fluorescence intensity, providing the greatest increase in 
maximum fluorescence intensity and the total number of increases above 20% that 
occurred upon pharmacological manipulation. The techniques used in this project 
allowed rapid measures of D1DR trafficking (30 minutes). Virally-transfected eGFP-
D1DRs internalized in response to dopamine or ethanol treatment. Internalization was 
also induced in response to ethanol pretreatment of dopamine, and the effect was greater 
than that observed after either treatment alone. This marked the first study to show acute 
ethanol action on the internalization of D1DRs. The identification of dopamine- and 
ethanol-induced D1DR internalization may aid in the understanding of addiction since 
D1DR internalization may be a neuroadaptation to chronic drug exposure. Specifically, 
D1DR internalization may be a cellular mechanism involved in the development of acute 
tolerance to ethanol.  
 
Receptors that internalize are no longer available for activation. In the case of exposure to 
ethanol or other drug of abuse, any enhanced extracellular dopamine levels would not 
activate D1DRs that had internalized. This might lead to increasing amounts of ethanol 
(or other abused drug) that would be required in order to achieve the original effect 
desired by an individual and is a characteristic of tolerance. As this effect happens 
quickly, the cellular mechanism of receptor internalization may be, at least in part, 
responsible for acute tolerance. 
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Internalization of some opioid receptors has been associated with recycling of the 
receptor to a fully active state so that desensitization was not observed (Whistler et al., 
1999; Alvarez et al., 2001). In this model, internalization was hypothesized to reactivate 
receptors that had been desensitized. For example, dephosphorylation of receptors may 
occur in endocytosed vesicles followed by reinsertion into the cellular membrane. 
However, D1DRs do not require internalization in order for receptor dephosphorylation 
to occur (Gardner et al., 2001). The state of the internalized receptor may thus be 
different for D1DRs and opiod receptors. Functional data of the D1DRs were not 
collected for our localization studies, although it is reasonable to assume that internalized 
D1DRs would not be accessible to ligands, and thus not be activated by them, which in 
turn would cause receptor desensitization.  
 
The use of a high dopamine concentration for some experiments may not necessarily 
represent a non-physiological level. For example, this high concentration of dopamine 
(100 uM) was necessary for maximal cAMP production in virally-infected BHK cells. 
This dopamine concentration was also required for receptor trafficking (in the absence of 
ethanol) in explants. However, the actual synaptic concentration of dopamine that 
reached these expressed receptors was unknown. Dopamine transporters would be 
expected to remove some of the dopamine from the synaptic space. Therefore, the 
dopamine concentration that produced D1DR trafficking may have been within a 
physiological range. 
 
5-2. FUTURE DIRECTIONS 
Since D1DRs cluster inside the cell upon ethanol treatment, it would be expected that 
ethanol may also induce other forms of D1DR desensitization. For example, cAMP 
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production by ethanol may decrease as a result of uncoupling of the D1DR from the G-
protein. cAMP assays in the absence and presence of ethanol could be performed to test 
for desensitization involving cAMP.  
 
Another form of D1DR desensitization is down regulation of gene expression. This type 
of desensitization would only be applicable to endogenously expressed D1DRs and could 
not be studied with this viral system which causes over expression of the protein through 
viral mediated RNA production of the gene to be studied. Moreover, down regulation 
would also not occur within the time frame of these experiments. The effect of chronic 
ethanol on receptor trafficking should be also studied as a comparison to the acute actions 
of ethanol in explants.  
 
Further studies could focus on the mechanism(s) of ethanol-induced D1DR 
desensitization by internalization. Candidates for these mechanistic studies could include 
mediators in the cAMP cascade. Pharmacological modulation of the enzymes of this 
cascade may inhibit the trafficking of D1DRs by ethanol. Another question to consider is 
if activation of dopaminergic cells in the VTA is entirely responsible for ethanol-induced 
D1DR trafficking, or if local cellular effects also play a part in ethanol’s action? One 
method to determine this would be the use of dissociated neurons from the ventral 
striatum (which contain the NAcc but are no longer innervated by the VTA) to study 
trafficking of D1DRs by ethanol. This preparation would allow the study of direct ethanol 
effects on neurons. Preliminary studies have been completed in this area, and the use of a 
new sindbis mutant (nsP2S726) expression system, displaying substantial reduced 
toxicity, has been developed (Jeromin et al., 2003; Kim et al., 2004). This mutant viral 
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expression system would allow studies in dissociated neurons without such toxicity 
problems.  
 
Other experiments could further corroborate the clustering seen in the current study. For 
example, electron microscopy could more definitively locate D1DRs after dopamine or 
ethanol treatment. Binding studies would provide another method to verify 
internalization. Moreover, other drugs of abuse could be tested in infected explants to 
determine if D1DR trafficking is a common effect for abused drugs. 
 
Many G-protein coupled receptors undergo receptor oligomerization. D1DRs have been 
associated with the NR1 subunit of NMDA receptors (Fiorentini et al., 2003) and the 
adenosine A1 receptor (Gines et al., 2000). Hetero-oligomerization of other dopamine 
receptor subtypes have also been proposed (Tsai and Hong, 2003). Homodimers or higher 
level homo-oligomers have not been observed conclusively but may exist 
physiologically. Moreover, co-immunoprecipitation techniques require solubilization 
which may form oligomers caused by solubilization artifacts (Bouvier, 2001). The 
presence of oligomers is determined by detection of BRET (bioluminescence resonant 
energy transfer) or FRET (fluorescence resonant energy transfer) in living cells. The 
effects of dopamine and/or ethanol treatment on hetero-oligomers of D1DRs would be an 
additional avenue for future studies. 
 
Finally, the pseudovirus causes over expression of D1DRs in vivo, and there are 
numerous areas in the brain where a local amplification in D1DRs may change a variety 
of behaviors. For example, our collaborators have observed that over expression of 
D1DRs in the bed nucleus of the amygdala caused a reduction in ethanol self-
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administration in C57BL/6J (B6) mice (RSA, 2004 Vancouver). Therefore, the virus is 
extraordinarily useful for molecular, biochemical, histological, and behavioral analysis of 





R1-AGAROSE PLATES:  
(100 mL to make 4 plates) 
luria broth base: 2.5 g 
agarose : 2.0 g 
100 mL dH20 
  Autoclave: liquid setting 15 minutes.  
When cool (but not gelled) add antibiotics. 
kanamycin 30ug/mL [stock solution 30 mg/mL, then use 1 uL/1 mL] 
ampicillin 50 ug/mL [stock solution 50 mg/mL, then use 1 uL/1 mL] 
 Pour ~ 25 mL into plates inside of sterile hood and let solidify, store at 4 °C. 
R2-LURIA BASE (LB) BROTH FOR GROWING BACTERIA  
(100 mL per maxi-prep isolation, 3 uL per mini prep isolation) 
 luria broth base: 2.5 g 
 100 mL dH20 
  Autoclave: liquid setting15 minutes 
 When cool add antibiotics (this does not gel) 
  kanamycin 30ug/mL  
  ampicillin 50 ug/mL 
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R3-AGAROSE GELS  
 DNA, 1% Gel  
agarose: 0.3 g 
d H20: 30 mL 
Microwave 30 seconds to allow agarose to dissolve, when cooled (but not 
gelled) add: 
50X TAE: 600 uL 
ethidium bromide (30 mg/mL): 3 uL 
Pour into gel mold with appropriate comb (inserted on the black side) for samples. 
Running Buffer, 1X TAE, is poured over the gel once it has solidified. Then samples are 
loaded in the openings the comb creates on the black side of the gel. A voltage is applied 
across the gel for separation of the DNA from the black side toward the red side.   
RNA, 0.7% agarose gels 
 Soak gel box and attachments in ~3N HCl for 15-30 minutes 
 Rinse out box with RNase free TBE 
 Make 0.7% RNA gel 
  agarose 0.21 g  
  RNase free TBE 30 mL 
  microwave 1 minute, then allow to cool 
ethidium bromide 3 uL  
Use RNase free TAE as the running buffer. All other steps are the same as DNA gels. 
R4-DEPC H2O 
Diethylpyrocarbonate (DEPC) is a very toxic substance that destroys enzymatic 
activity by modifying –NH, -SH, and –OH groups in RNases and other proteins. DEPC 
H2O is used to make all RNase free solutions. 
Make 1 L of DEPC H2O: 
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In a 1 L autoclavable glass bottle add 1 mL of DEPC to 999 mL dH2O and over 
low heat and mix overnight. The next morning this mixture is autoclaved on a liquid 
setting for 15 minutes. The autoclaving will inactivate the DEPC but it should still be 
treated carefully and handled to avoid contamination with RNases. 
R5-50 MM TRIS-CL, 100 MM NACL, 0.5 MM EDTA = TNE BUFFER 
1 mM Tris-Cl, pH= 7.4 5 mL  
2 M NaCl   3.33 mL 
0.25 M EDTA   200 uL 
qs with DEPC H2O to 100mL 
R6-55% SUCROSE IN TNE BUFFER 
 55 g sucrose/100 mL TNE Buffer, autoclave 15 minutes 
R7-20% SUCROSE IN TNE BUFFER 
 20 g sucrose/ 100 mL TNE Buffer, autoclave 15 minutes 
Appendix II 
PROTOCOLS (P) 
P1-IN VITRO TRANSCRIPTION OF SINDBIS VIRUS DNA 
DNA, enzymes, kits and buffers in –20 °C freezer  
RNA in –80 °C freezer  
Most other solutions are in either 4o fridge, or at room temperature in cabinets 
1) Cut DNA to make circular DNA linear. Different constructs will require different 
enzymes to linearalize the DNA. 
pSinRep5GLUR1  pSinRep5D1   DH(26)S 
DNA 1-10 ug   DNA 5-10 ug   DNA 5-10 ug 
BSA 1 uL   BSA 1 uL   BSA 1 uL 
Buffer D 10 uL  Buffer 2 10X 10uL  Buffer 2 10 X 10 uL 
Not1 5 uL   Xho1 5 uL   Xho1 5 uL 
 
Balance with 
DEPC WATER  DEPC WATER    DEPC WATER 
    total volume 100 uL  100 uL    100 uL  
 
Tap tubes, spin, incubate at 37°C for 3 hours. 
2) Make 0.7% agarose gel: 
0.21 g agarose
30 mL water 
600 uL 50X TAE 
3 uL ethidium bromide 
 
Microwave > 1 min
3) Add 3 uL of loading gel to 3 uL of each sample and run on gel with ~ 5 uL 1 kb 
ladder. Add TAE to the box, connect cables to matching colors and run at  
85 V 
4) Protease K treatment (removes extra enzymes) 
Add 1 uL to each tube and incubate at 37 °C for 30 minutes. 
5) Phenol Chloroform Isolation (done in hood to avoid fumes) 
a. Add 1x the volume of phenol:CHCl3:IAA shake, and centrifuge at 
14,000 rpm for 1 minute, take top layer, discard bottom layer 
b. Add 1x the volume of phenol:CHCl3:IAA shake, and centrifuge at 
14,000 rpm for 1 minute, take top layer, discard bottom layer 
c. Add 1x the volume of chloroform shake, and centrifuge at 14,000 
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rpm for 1 minute, take top layer, discard bottom layer 
d. Add 1/10x 3 M sodium acetate 
e. Add 2x 100% ethanol 
f. Mix and incubate in –80 °C freezer for 1-12 hours   
g. Centrifuge balanced tubes for 15 minutes at 14,000 rpm 
  Pipette off liquid to dry out pellet 
h. Add 4 uL DEPC H2O to resuspend pellet, let sit ~ 10 minutes at room 
temperature. 
6) mMessage mMachine SP6 Kit (Ambion, Austin, TX catalog # 1340 ) 
 for each reaction: 
   
 4 uL DEPC linearized DNA 
10 uL 2x NTP/Cap 
 2 uL 10x Reaction Buffer 
 2 uL Enzyme mix 
 1 uL GTP 
Incubate for 1 hour at 37 °C 
Then add 1uL enzyme mix and incubate for a 2 nd hour at 37 °C. 
7) Add 130 uL DEPC H2O 
8) Phenol:chloroform isolation again 
a. Add 1x the volume of phenol:CHCl3:IAA shake, and centrifuge at 
14,000 rpm for 1 minute, take top layer, discard bottom layer 
b. Add 1x the volume of chloroform shake, and centrifuge at 14,000 rpm for 
1 minute, take top layer, discard bottom layer 
c. Add 1/10x 3 M sodium acetate 
d. Add 2x 100% ethanol 
e. Mix and place in –80 °C freezer for 1-12 hours 
9) Centrifuge balanced tubes for 15 minutes at 14,000 rpm at 4 °C. 
10) Prepare RNA gel 
 Soak gel box and attachments in ~3N HCl for 15-30 minutes 
 Rinse out box with RNase free TBE 
 Make 0.7% RNA gel 
  agarose  0.21 g  
  RNase free TBE 30 mL 
  ethidium bromide 3 uL 
11) Pipette off fluid 
12) Add 200 uL 80% ethanol, centrifuge 5 minutes at 14,000 rpm 
13) Pipette off all fluid let air dry 
14) Add 20 uL DEPC H2O, let sit at room temperature 
  1uL RNA + 3 uL loading dye run on gel (using RNase free TBE in bath) 
  1uL RNA for Nano-drop analysis 
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P2-ELECTROPORATION OF BHK CELLS WITH SINDBIS VECTORS 
RNA kept at -80 °C freezer 
Biorad Gene Pulsar in Dr. Bergessons Lab in MBB 
 
1) Wash cells in 10 mL RNase free PBS without cations at room temperature. 
2) Add 3 mL trypsin per flask, one flask at a time. Under trypsinizing results in not 
enough cells detatching, over trypsinizing results in clumping and inefficient 
electroporation. 
3) Stop trypsinization reaction by adding 5 mL media. 
4) Pour this mixture of cells, trypsin, and media into a 15 mL sterile tube. 
5) Centrifuge these cells for 5 minutes at 500 rpm at room temperature. 
6) Resuspend the cells in 5 mL ice cold RNase free PBS without cations. Centrifuge 
 for 5 minutes at 500 rpm at room temperature. 
7) Repeat wash by resuspending the cells in 5 mL ice cold RNase free PBS without 
 cations. Centrifuge for 5 minutes at 500 rpm at room temperature. 
8) Take an aliquot of the cells and determine the total number of cells.  
 
(Hemactymotor average) x (104 ) x (volume of cells) = total number of cells 
 
9) Third RNase free PBS wash as in #6 or 7 
10) Resuspend the cells at a density of 1.5 x107 cells/mL ice cold RNase free PBS 
 without cations. 
11) In ice cold eppendorf tubes mix 500 uL of cells + 10-15 ug DH(26)S RNA + 10- 
 15 ug RNA of pSinRep5 containing your gene of interest. 
12) Transfer this mixture to cuvettes and shock them 2x: 
 BioradGene Pulsar with Pulse Controller 
 0.2 mm electrode gap cuvettes from biorad 
 1.5 kV, 25 uFD, resistance = infinity 
 time constant should result in 0.7 msec 
13) After shock let cuvettes sit at room temperature for 10 minutes. Using sterile glass 
 pipette remove all solution especially foamy cells and add 9.5 mL MEM + 
 10% FBS. Then pipette 2 mL into 35 mm dishes. 
14) Verify glowing BHK cells in 24-60 hours. 
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